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Abstract 
The purpose of the present study is to identify psychological factors that predict a longer 
length of stay (LOS) and minimal improvement in a headache inpatient unit. Research 
shows that some psychological factors associated with headache disorders, such as 
anxiety, depression, and maladaptive coping skills, can complicate the disorder. The 
present study theorized that psychological factors that complicate the headache disorder 
would predict a longer LOS and minimal improvement. The present study used a quasi-
experimental, prospective, cross-sectional survey research design, with multiple 
regression analyses. There was a total of 51 completed protocols. Of those completed 
protocols, 78% of participants were age 35 years and older. Of consenting participants, 
82% were Caucasian women. Results indicated that the hypothesized model to predict 
LOS and minimal improvement was not significant. Paired-samples t-test analyses 
indicated that there were significant reductions of BPI-SF interference and severity scores 
after inpatient treatment, presenting a basis for further research involving comparison 
groups.  
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Chapter One: Introduction 
Statement of the Problem 
Headache for most people, although a nuisance, is usually infrequent and 
resolvable. However, for a proportion of the population, headache is a chronic disorder 
that is disabling, significantly impeding quality of life (Lipton & Newman, 2003). 
According to Jensen and Stovner (2008), “the scope and scale of the burden of headache 
is underestimated, and headache disorders are universally under-recognized and 
undertreated” (p. 354). Globally, of the adult population, 47% have a general headache 
condition, 10% have a migraine disorder, 38% have Tension-Type Headache, and 3% 
have a chronic headache disorder (Jensen & Stovner, 2008). Disability from Tension-
Type Headache is greater than that from migraine because of its higher prevalence, 
despite migraine being considered the ninth most costly neurological condition for both 
genders, and the third most costly for women (Jensen & Stovner, 2008). Headache is one 
of the 10 most disabling disorders for both genders, and the fifth most disabling for 
women (Jensen & Stovner, 2008).  
Prevalence rates for debilitating headache disorders vary depending on 
demographic characteristics, such as age, region of the world, and gender (Diamond et 
al., 2007). A study conducted from 1992 to 2001 found that visits for headaches in 
emergency departments occurred with average rates of 10.9 for women, versus 4.6 for 
men, per 1,000 persons in the United States population (Goldstein, Camargo, Pelletier, & 
Edlow, 2006). In terms of race, Goldstein et al. (2006) found that the rate was 7.5 for 
Caucasian patients, 12.0 for African American patients, and 2.2 for other races. The rate 
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for Hispanic patients was 4.6, while the rate for nonHispanic patients was 6.5. They also 
found that emergency department visits for headaches were most common for patients in 
the age range of 18 - 49 years. According to Freitag, Lake, Lipton, and Cady (2004), 
African American men and women have prevalence rates for Chronic Tension-Type 
Headache, Chronic Migraine, and Frequent Headache of Other Types that are lower than 
those for Caucasian men and women. In regards to region, Migraine is more prevalent in 
Europe (14.8%) and North America (11.1%) than it is in Africa (4%) (Jensen & Stovner, 
2008). Tension-Type Headache is more prevalent in Europe (80%) than it is in Asia and 
the Americas (20 - 30%). Chronic headache is most common in Central and South 
America (5%) and least common in Africa (1.7%). According to Jensen and Stovner 
(2008), the male to female ratio for Migraine varies from 1:2 to 1:3, with women having 
more Migraine without Aura than Migraine with Aura. For Tension-Type Headache, 
women are only slightly more affected, with a ratio of 4:5. Interestingly, there is no 
gender difference in incidence for prepubertal children. In terms of age, Tension-Type 
Headache peaks between the ages of 30 and 39 years, for both genders. Onset of migraine 
occurs in the 20’s and 30’s; it peaks in the 40’s and declines thereafter. Chronic headache 
disorders span a lifetime, increasing until the 50’s, with only a minor decline with age.  
In addition to physical pain and suffering, patients suffer economic, occupational, 
and social losses (Krymchantowski, Adriano, De Góes, Moreira, & Da Cunha Jevoux, 
2007). The second American Migraine Study conducted in 1999 found that only 9% of 
participants were able to work or function normally with their headache condition (Lipton 
& Newman, 2003). Likewise, 59% of participants reported that they missed family 
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functions or social leisure activities. Stovner and Hagen (2006) found that headache 
presents more of a burden for patients than do disorders such as Epilepsy, Multiple 
Sclerosis, and Parkinson’s disease, as measured by the Disability-Adjusted Life-Years. 
Yet, despite the burden of migraine, there are still many underdiagnosed cases that do not 
receive appropriate treatment (Diamond et al., 2007).   
Aside from the impact headaches have on patients’ lives, they also create 
significant direct and indirect costs for society, as reviewed in the study by Munakata et 
al., (2009). The most recent American Migraine Prevalence and Prevention Study, a five-
year longitudinal study, evaluated the impact of migraine on utilization of health-care 
resources and on productivity loss (Munakata et al., 2009). Data from the first 2 years of 
the study showed that participants with transformed migraine reported more primary-care 
visits, neurology and headache-specialist visits, emergency-room visits, and pain clinic 
visits as compared to participants with episodic migraine. In terms of productivity, 
participants with transformed migraine reported significantly more time missed from 
work or school because of headaches. Participants with transformed migraine also 
reported more time at work or school when productivity was reduced by half because of 
headaches. Participants with transformed migraine incurred significantly more direct and 
indirect costs ($7,750 per patient, per year) as compared to participants with episodic 
migraine ($1,757 per patient, per year).  Lost productivity accounted for 55.7% of the 
costs for participants with migraine and 69.6% of the costs for participants with 
transformed migraine. Specifically, with indirect costs resulting from absenteeism, 
participants with migraine lost 13.7 hours per person, per year, while participants with 
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transformed migraine lost 85.7 hours per person, per year. With indirect costs caused by 
reduced productivity, participants with migraine lost 48.3 hours per person, per year, 
while participants with transformed migraine lost 256 hours per person, per year. 
To reduce costs from headache, patients must be treated by appropriate 
professionals in appropriate settings (Saper, Silberstein, Gordon, Hamel, & Swidan, 
1999). Inpatient treatment for patients with headache is sometimes a warranted and 
necessary evil, that is, “the severity of the illness must match the intensity of the service” 
(Saper et al., 1999, p.13). According to Saper et al. (1999), when hospitalization is 
appropriate to patients’ conditions, it can reduce both direct and indirect costs. For 
example, successful hospitalizations can lead to longer periods of headache-free time and 
consequently less frequent medical care, thus reducing associated direct costs. Likewise, 
more headache free time results in less frequent work absences, thus reducing indirect 
costs. On the other hand, if hospitalization is not appropriate, or if there is an 
unsuccessful outcome, both direct and indirect costs increase. Examining factors 
associated with a longer length of stay (LOS) and minimal improvement potentially can 
provide an efficient way to identify patients who need more support before or during 
hospitalization in order to prevent and/or remediate factors that impede success of 
inpatient treatment.   
The relationship between LOS and treatment outcome for inpatients with 
headache is an important area of study, not only because of the limited research on the 
topic but also because of the potential to reduce costs associated with headaches. 
Likewise, few studies have found treatment parameters that predict success for inpatient 
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treatment (Grazzi et al., 2002). Identifying factors associated with a longer LOS and 
minimal improvement can lead to the development of a rubric for teams who treat 
inpatients with headache that can help them to better decide specialized care for 
refractory cases in order to promote a timely, successful hospitalization.  
Purpose of the Study 
Research focused on factors associated with minimal improvement has not been 
clear about the way factors interact to predict a poorer outcome or about the stipulations 
of individual differences that may preclude predictive value for certain individuals. 
According to Grazzi et al. (2002), “multiple factors interact in varied ways to determine a 
patient’s response to treatment” (p. 7). The purpose of the present study is to determine 
whether a combination of psychological variables predicts a longer LOS and minimal 
improvement for inpatients with headache, in order to create a rubric that directs 
specialized care for refractory cases. The study will analyze the significance of potential 
predictors in determining a longer LOS and minimal improvement. This author proposed 
that psychological factors that complicate the headache disorder will be associated with a 
longer LOS and minimal improvement. 
Overview of Literature Review 
Owing to the dearth of research on psychological factors that predict inpatient 
treatment outcome and LOS, the literature review focuses primarily on psychological and 
demographic factors that complicate headache disorders, and may lead to a poorer 
treatment outcome. The literature review describes headache classifications and the 
medical and psychological pathologies of and treatments for headaches. Research on the 
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relationships among pain and psychological and demographic factors will be presented. 
Likewise, the biopsychosocial model and stress diathesis model will be presented to 
review the connection between biology and psychology in the pathology of medical 
conditions. 
Relevance to the Broad and General Knowledge Base of Psychology 
 The present study emphasizes the goal to expand the value of psychology to other 
disciplines, specifically the medical field. This study aims to incorporate the use of 
psychological measures in hospital settings in order for the field of psychology to define 
and expand further its role in the medical field. This study emphasizes the need for 
medical and mental-health professionals to collaborate to discuss the ways medical and 
psychological factors interact to result in minimal treatment outcome.  
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Chapter Two: Literature Review 
Headache Disorders 
Headache is a complex disorder with various etiological contributors, both genetic 
and environmental (International Headache Society, IHS; 2004). The lack of a single 
clear-cut headache etiology caused frustration for patients. There are many variations of 
headache disorders, likely caused by the numerous potential combinations of etiological 
contributors. As is applicable to this study, headache diagnoses will be reviewed to reveal 
their impact on quality of life.  
According to the International Classification of Headache Disorders, 2
nd
 edition, 
the first step in diagnosing headache is to determine whether the headache is a primary or 
secondary disorder (IHS, 2004). Primary refers to headaches that are not caused by 
another disorder known to produce headaches. Secondary refers to headaches that are 
caused by another disorder. Both primary and secondary diagnoses can be given 
simultaneously (IHS, 2004). Basic primary headache categories, such as migraine and 
tension-type, will be reviewed. Secondary headaches, such as Medication Overuse 
Headache, will be discussed also, as they frequently appear in inpatient settings (Saper, 
2008).  
Migraine is divided into two main categories, Migraine with Aura and Migraine 
without Aura (IHS, 2004). To meet diagnostic criteria for Migraine without Aura, an 
individual must have at least five attacks lasting between 4-72 hours per month (untreated 
or unsuccessfully treated). Headache pain also must meet two of the following 
characteristics: unilateral, pulsating, moderate to severe intensity, and/or aggravated by 
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physical activity. Additionally, during a headache, an individual must have at least one of 
the following symptoms: nausea and/or vomiting or photophobia and/or phonophobia 
(sensitivity to light and sound, respectively).  
Migraine with Aura is characterized by focal neurological symptoms that precede 
and/or accompany the headache (IHS, 2004). To meet diagnostic criteria, an individual 
must have at least two attacks per month with no motor weakness and at least one of the 
following symptoms: fully reversible visual homonymous symptoms, including flickering 
lights, spots, lines, loss of vision; fully reversible unilateral sensory symptoms, including 
pins and needle, numbness; and/or a fully reversible dysphasic speech disturbance. At 
least one aura symptom must develop in 5 minutes or less, and/or aura symptoms must 
occur in succession for at least 5 minutes. Each aura symptom must last for at least 5 
minutes.   
There are diagnoses to account for disorders that are similar to Migraine with 
Aura and Migraine without Aura (IHS, 2004). Typical Migraine With Aura is diagnosed 
when there is aura with a headache meeting the criteria for Migraine without Aura. 
Typical Nonmigraine Headache with Aura is diagnosed when typical visual, sensory, 
and/or auditory aura symptoms occur without a headache characterized by the criteria of 
Migraine without Aura. 
Differentiations of migraine include diagnoses such as Familial Hemiplegic 
Migraine, Sporadic Hemiplegic Migraine, Basilar-Type Migraine, and Retinal Migraine 
(IHS, 2004). Familial Hemiplegic Migraine is diagnosed if the aura associated with 
Typical Migraine with Aura includes motor weakness, and at least one first- or second-
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degree relative has migraine aura with motor weakness. Sporadic Hemiplegic Migraine is 
diagnosed when there is motor weakness without a familial link. Basilar-Type Migraine 
is distinguished from other migraine disorders by its simultaneous effect on both 
hemispheres. Basilar-Type Migraine is diagnosed when at least two attacks per month 
occur with aura, without motor weakness, and with two of the following symptoms: 
dysarthria (difficulty articulating words), vertigo, tinnitus, hypacusia (hearing 
impairment), diplopia (double vision), visual symptoms in both temporal and nasal fields 
of both eyes, ataxia, decreased level of consciousness, and/or simultaneous bilateral 
paraesthesias. Retinal Migraine is characterized by reversible monocular visual 
disturbance, such as scintillations (flashing or sparkling), scotomata, and/or blindness. 
Complications also can occur with migraine disorders that warrant additional 
diagnoses, such as Chronic Migraine, Persistent Aura without Infarction, Migrainous 
Infarction, Status Migrainosus, and Migraine-Triggered Seizure (IHS, 2004). Chronic 
Migraine is diagnosed when a migraine headache occurs on 15 or more days per month 
for more than 3 months in the absence of medication overuse. Persistent Aura without 
Infarction is diagnosed when one or more of the aura symptoms typical of a previous 
Migraine with Aura attack lasts for more than a week without evidence of an infarction. 
Migrainous Infarction is diagnosed when one or more migrainous aura symptoms are 
associated with an ischaemic brain lesion. Status Migrainosus is diagnosed when a severe 
migraine typical of Migraine without Aura lasts more than 72 hours. Migraine-Triggered 
Seizure is diagnosed when a migraine aura typical of Migraine with Aura triggers a 
seizure.  
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Tension-Type Headache is divided into the following categories: Infrequent 
Episodic Tension-Type Headache, Frequent Episodic Tension-Type Headache, Chronic 
Tension-Type Headache, and Probable Tension-Type Headache (IHS, 2004). Infrequent 
Episodic Tension-Type Headache is diagnosed when two of the following characteristics 
are met: bilateral location, pressing or tightening quality that is nonpulsating, mild or 
moderate intensity, and/or not aggravated by routine physical activity. While there may 
be anorexia, there is no nausea or vomiting, and there is not more than one symptom of 
photophobia or phonophobia. Headaches must last at least 30 minutes and can last up to 7 
days. At least 10 episodes must occur, but no more than once a month and 12 days per 
year. Frequent Episodic Tension-Type Headache has the same criteria as Infrequent 
Episodic Tension-Type Headache except that headaches occur more than once a month 
but fewer than 15 days per month, for at least 3 months. 
Chronic Tension-Type Headache, also labeled as New Daily-Persistent Headache, 
is diagnosed after 3 days of unambiguous symptoms similar to Frequent Episodic 
Tension-Type Headache symptoms that last for hours or are continuous (IHS, 2004). 
Probable diagnoses for infrequent and frequent episodic headaches (Probable Infrequent 
Episodic Tension-Type Headache and Probable Frequent Episodic Tension-Type 
Headache) are given when patients meet all but one criterion. Probable Chronic Tension-
Type Headache is diagnosed when all criteria are met for Chronic Tension-Type 
Headache, and within the past 2 months some form of Medication-Overuse Headache is 
present.  
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Medication-Overuse Headache is divided into several categories: Ergotamine-
Overuse Headache, Analgesic-Overuse Headache, Triptan-Overuse Headache, Opioid-
Overuse Headache, and Combination Medication-Overuse Headache (IHS, 2004). 
Ergotamine-Overuse Headache is diagnosed when a headache is present for more than 15 
days per month with at least one of the following characteristics: bilateral, 
pressing/tightening (nonpulsating) quality and/or mild or moderate in intensity (IHS, 
2004). Likewise, the headache must have developed or worsened as a result of 
ergotamine overuse. Headache also must resolve or revert to its usual pattern within 2 
months after stopping the ergotamine. Analgesic-Overuse Headache follows the same 
diagnostic criteria as Ergotamine-Overuse Headache. Triptan-Overuse Headache is 
diagnosed when a headache is present on more than 15 days per month and meets at least 
one of the following characteristics: predominantly unilateral, pulsating quality; moderate 
or severe intensity; and/or aggravated by or causing avoidance of routine physical activity 
(IHS, 2004). Headache also must be associated with at least one of the following 
symptoms: nausea, vomiting, photophobia, or phonophobia. Additionally, headache 
frequency must have increased during triptan overuse. Headache also must revert to its 
usual pattern within 2 months after stopping the triptan.  
Opioid-Overuse Headache is diagnosed when headache is present for more than 
15 days per month and is associated with development of headache or worsening of 
headache during opioid overuse (IHS, 2004). Likewise, headache must resolve or revert 
to its usual pattern after 2 months of stopping opioids. Combination Medication-Overuse 
Headache is diagnosed when headache is present for fewer than 15 days per month and 
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meets at least one of the following characteristics: bilateral, pressing/tightening 
(nonpulsating) quality, or mild or moderate intensity (IHS, 2004). Headache also must 
develop or worsen during combination-medication overuse and resolve or revert to its 
usual pattern within 2 months after stopping combination medications.  
There are several reasons for the development of Medication-Overuse Headache. 
Patients may overuse medication for pain relief and to function with daily responsibilities 
because of inadequate control from medical care (Saper, 2008). Patients with headache 
commonly overuse medication to function, rather than to escape from problems or to get 
a high (Primavera & Kaiser, 1993; Saper, 2008). Patients with headache may also 
overuse because of a low pain tolerance, a fear of pain, and/or a belief of entitlement to 
be pain free (Saper, 2008). Medication-Overuse Headache is less likely in patients with 
Chronic Tension-Type Headache. However, Episodic Tension-Type Headache in patients 
who overuse medications can transform easily to a chronic headache disorder (IHS, 
2004). Patients who overuse acute medications rarely respond to preventative 
medications. 
Headache Pathology 
Medical 
 The pathology of pain in general involves tissue damage, injury, or inappropriate 
activation of the pain-producing pathways of the central nervous system (CNS) or the 
peripheral nervous system (PNS; Goadsby & Raskin, 2008). Tissue damage stimulates 
peripheral nociceptors (pain reception), which is a normal response of a healthy nervous 
system (Goadsby & Raskin, 2008).  
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While the key structures involved in headache are known, the pathology is more 
obscure (Goadsby & Raskin, 2008). The trigeminovascular system, the large intracranial 
vessels, dura mater, and the trigeminal nerve that innervates them, is involved in 
headache. The caudal portion of the trigeminal nucleus and the pain modulatory systems 
in the brain that receive input from the trigeminal nociceptors also are involved in 
headache (Goadsby & Raskin, 2008). Several accepted etiological models for migraine 
include explanations of multimechanisms, genetic mutations, cortical spreading 
depression (CSD), and neurotransmitters (Barbas & Schuyler, 2006). The pathology of 
Tension-Type Headache is more obscure (Edmeads, 1998). There are few known 
contributing factors to Tension-Type Headache (Barbas & Schuyler, 2006). 
 Migraine is no longer conceptualized as simply a vascular condition resulting 
from blood vessel dilation (Thomas Jefferson University, n.d.). Multiple mechanisms 
contribute to the onset of migraine. Specifically, a chain of events, beginning with 
inflammation, leads to norciception, vasodilation, and central and peripheral 
sensitization. Inflammation involving hormone-like prostaglandins and neuropeptides 
results in vasodilation—the widening of the blood vessels. Vasodilation activates 
norciception, which transmits pain signals to the thalamus and cerebral cortex, the 
location of the first sensation of pain. Activation of the nociceptors leads to increased 
stimulation of the nerve cells in the trigeminal nerve (the main sensory nerve). Prolonged 
stimulation of the trigeminal nerve results in central sensitization. The multimechanism 
explanation accounts for migraine symptoms, such as sensitivity to light and noise and/or 
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nausea and vomiting. For example, stimulation of the trigeminal nerve may affect any of 
the nerve’s three branches, resulting in sinus, facial, and/or neck pain. 
Even when genetics do not appear to play a role in migraine, they are implicated 
(Barbas & Schuyler, 2006). In addition to the increased prevalence of migraine among 
family members, five susceptible gene locations on four chromosomes have been found 
to be linked significantly to Migraine with Aura and Migraine without Aura. Likewise, 
Familial Hemiplegic Migraine may provide insight on whether there is a shared cellular 
pathogenesis between the Familial Hemiplegic Migraine, more common migraine 
subtypes, and other headache conditions (Barbas & Schuyler, 2006; Sanchez-del-Rio, 
Reuter, & Moskowitz, 2006). However, there is no single gene responsible for Migraine 
with Aura and Migraine without Aura (Barbas & Schuyler, 2006). 
According to Sanchez-del-Rio et al., (2006), genetic mutations lead to migraine 
aura through CSD. CSD starts with cortical stimulation, followed by a slow wave of 
neuronal depolarization that travels across the cortex, resulting in a long-lasting 
suppression of neuronal activity. The Familial Hemiplegic Migraine mutations make the 
brain more susceptible to CSD through excessive synaptic glutamate release, decreased 
removal of glutamate and potassium from the synaptic cleft, or persistent sodium influx. 
CSD can be induced experimentally by trauma to the cortex, high extracellular 
concentrations of glutamate or potassium, inhibition of NA+/ K+ -ATPase, and other 
stimuli. Overall, migraine develops from environmental and genetic causes that enhance 
susceptibility to hyperactivity in the cortex, resulting in CSD. However, the complete 
picture of the initiation of migraine is still a mystery. 
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Neurotransmitters, such as serotonin, are implicated in migraines (Hamel, 2007). 
While most studies have not supported a genetic role in serotonin synthesis, there is 
strong support for a link between low brain serotonin neurotransmission and migraine 
headache (Hamel, 2007). A disposition for low serotonin levels facilitates CSD-induced 
trigeminal nociception (Hamel, 2007). Similar to migraine, depression is also a disorder 
of low serotonin. Therefore, the comorbidity between depression and migraine is not 
surprising (Cahill & Murphy, 2004). However, one family study did not find a genetic 
basis for the association between migraine and depression (Cahill & Murphy, 2004). 
Twin studies, when conducted, may prove otherwise. As of now, there is no conclusive 
evidence for a common genetic etiology for both disorders (Cahill & Murphy, 2004). The 
neurobiological relationship between headaches and psychological factors will be 
discussed in more detail in the cognitive/affective and biological components section. 
While the etiology of Tension-Type Headache is more obscure, several known 
psychological, environmental, and neurological factors are linked to Tension-Type 
Headache (Bendtsen & Jensen, 2006; Edmeads, 1998). Neurologically, pericranial 
myofascial pain sensitivity, which is common in patients with Tension-Type Headache, 
could be a result of peripheral sensitization of myofascial nociceptors (Bendtsen & 
Jensen, 2006). Studies also suggest that with Chronic Tension-Type Headache, the 
central nervous system is sensitized at both the spinal dorsal horn/trigeminal nucleus and 
supraspinally (Bendtsen & Jensen, 2006). However, central pain processing seems to be 
normal in patients with Episodic Tension-Type Headache (Bendtsen & Jensen, 2006). 
Stress and fatigue are known to aggravate Tension-Type Headache, and depression is 
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also a common factor (Edmeads, 1998). Epidemiological and twin studies found no 
evidence of a strong genetic susceptibility for Tension-Type Headache (Barbas & 
Schuyler, 2006). 
Psychological/environmental mechanisms 
 Biopsychosocial model. The model for understanding headaches has progressed 
past the biomedical model to the biopsychosocial model (Nicholson, Houle, Rhudy, & 
Norton, 2007). The main theme of the biopsychosocial model is the interplay among 
biological, psychological, and social processes. Each factor has a unique influence on 
headaches; not one is more or less important than the others (Nicholson et al., 2007). 
Psychological factors, such as depression, anxiety, coping skills, stress, neuroticism, 
catastrophizing, locus of control, self-efficacy, emotional inhibition, and negative 
emotions, can play a role in the development, course, and outcome of headaches 
(Nicholson et al., 2007). Overall, research shows that psychological problems have an 
important influence on the suffering patients with pain (Dersh, Polatin, & Gatchel, 2002; 
Korff & Simon, 1996). For example, studies show that psychological factors can trigger 
headache potentiation, pain perception, disability, and treatment outcome (Korff & 
Simon, 1996; Nicholson et al., 2007). 
Biopsychosocial theories categorize the concept of pain into four dimensions: 
nociception, pain, suffering, and pain behavior (Gatchel, 2004). Nociception occurs when 
nerves send messages conveying tissue damage to the brain. Pain is a subjective 
experience that involves the transduction, transmission, and modulation of sensory input. 
Sensory input may be filtered through genetic composition, learning history, 
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psychological status, and sociocultural influences. Suffering is defined as an emotional 
reaction to nociception or an aversive event associated with nociception. Pain behavior is 
defined as the reactions people have when they are suffering or in pain, such as avoiding 
activities.  
Gatchel proposed a biopsychosocial interactive theory of health and illness 
(Gatchel, 2004). It proposes that affective, cognitive, biological, and somatic processes 
influence the autonomic, endocrine, and immune systems through afferent and efferent 
feedback. Underlying all these processes are genetic predispositions. The interactive 
processes can influence activities of daily living, environmental stressors, interpersonal 
relationships, family environment, social support/isolation, social expectations, cultural 
factors, insurance issues, previous treatment experiences, and work history, all of which 
also can influence psychological and biological factors. 
Gatchel developed a biopsychosocial theory to explain the progression of acute 
pain to chronic pain (Dersh et al., 2002). He proposed three stages: normal emotional 
reactions, a wider range of psychological problems, and habituation to or acceptance of 
some aspects of the sick role. The first stage is characterized by normal emotional 
reactions to pain, such as anxiety, fear, and worry. During the second stage, after 2 to 4 
months of persistent pain, emotional reactions can persist into psychological problems, 
such as learned helplessness, anger, distress, and somatization. According to the stress 
diathesis model, psychological problems that develop in the context of pain depend on an 
individual’s preexisting psychological and personality characteristics, socioeconomic 
factors, and other environmental conditions. The stress of coping with chronic pain 
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exacerbates the individual’s preexisting characteristics. During the third stage, 
psychological problems persist to the point where the individual’s life revolves around 
pain as a result of chronicity. During this stage, patients can habituate to some aspects of 
the sick role. They may use the chronic condition as an excuse to avoid responsibility and 
social obligations, which could become a reinforcer for maintaining the chronic 
condition. 
Stress diathesis model. The stress diathesis model is a component of the broader 
biopsychosocial model (Korszun, 2002). It is a widely accepted model for stress-related 
disorders (Korszun, 2002). The model proposes that stress interacts with underlying 
predispositions, thereby causing disorders. Stress can include physical stress, such as a 
virus or injury, or psychological stress, such as an event that threatens an individual’s 
homoeostasis (Korszun, 2002). For example, an individual who develops a chronic pain 
condition may have predispositions, such as negative schemas or deficits in instrumental 
skills (Dersh et al., 2002). The stress of chronic pain then may activate the 
predispositions, resulting in depression (Dersh et al., 2002). 
 The stress diathesis model can specify how stress aggravates and/or contributes to 
the development of a headache disorder (Nash & Thebarge, 2006). For example, a 
preexisting acquired or inherited vulnerability to developing a headache disorder, when 
aggravated by stress, can develop into a headache disorder. Electrophysiological studies 
suggest stress sensitivity may be a contributor to migraine disorders. Individuals with 
migraine have higher levels of cortical arousal between migraine episodes with a lack of 
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habituation. Stress sensitivity may develop from the headache disorder, or it may be a 
correlate of shared pathophysiology (i.e., serotonin dysfunction). 
Link between cognitive/affective and biological components. Studies show that 
neural circuits of both headache and cognitive-affective activity are highly intertwined 
(Nicholson et al., 2007). The pain circuit comprises the periaqueductal gray, serotonin (5-
HT) neurons of the rostral ventromedial medulla, and norepinephrine of the dorsolateral 
pontomesenchephalic tegmentum (Nicholson et al., 2007). Serotonin is involved in pain 
and cognitive-affective activity in a few important ways: production of emotional pain 
reactions; obsessive rumination; sleep/awake cycles; long-term, low-level pain 
transmission; and regulation of neurotransmitters responsible for alertness (Buelow, 
Herbert, & Buelow, 2000). Norepinephrine is involved in maintaining wakefulness and 
alertness and the fight-or-flight response (Buelow et al., 2000). Norepinephrine also has 
an analgesic effect on pain by slowing the release of substance P (Buelow et al., 2000). 
Likewise, some of the pain-relieving effects of opioid analgesics, serotonin agonists, and 
norepinephrine agonists occur through the pain circuit (Buelow et al., 2000). 
According to Nicholson et al. (2007), pain involves multiple brain regions, which 
are also the same regions involved in emotion, attention, and stress, among other 
psychological phenomena. Specifically, the amygdala area of the limbic system can 
activate the pain circuit, and it is also an important area for emotion. The anterior 
cingulated cortex, orbitofrontal cortex, insula, and hippocampus are implicated in pain 
modulation through attention, placebo, expectation, perceptions of control, and anxiety. 
The interaction between psychological and biological systems may explain the influence 
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of long-term changes through neuroplasticity and sensitization on the development of 
headache chronification and comorbid mood disorders.  
Delgado (2006) reported that dysfunction in ascending and descending pathways 
of the serotonergic and noradrenergic systems can result in depression and chronic pain. 
When the serotonergic and noradrenergic pathways are not working properly, heightened 
sensitivity to pain and pain from normally nonpainful stimuli can occur. Antidepressant 
medications that act on the serotonergic and/or noradrenergic systems not only improve 
mood but also treat symptoms of chronic pain.  
 According to Cahill and Murphy (2004), the serotonin dysfunction involved in 
migraine and depression represents an underactive serotonergic system. Serotonin is 
proposed to be involved in migraine as evidenced by changes in serotonin and its 
metabolites during migraine attacks, the ability of serotonin to trigger migraine attacks, 
and the implication of serotonin in treatment (Cahill & Murphy, 2004). To date, seven 
serotonin receptors have been identified: 5-HT1 through 5-HT7 (Sheftell & Atlas, 2002). 
Evidence suggests that 5-HT1 is involved in migraines, since effective triptan 
medications are 5-HT1 agonists (Sheftell & Atlas, 2002). Serotonin also has been 
implicated in anxiety disorders, eating disorders, obsessive-compulsive disorder, (OCD), 
and Tension-Type Headache (Sheftell & Atlas, 2002).  
 Theories propose that psychological factors modulate pain through shared circuits 
(Nicholson et al., 2007). Negative affect may influence headaches by activating a 
defensive system that creates neural and physiological changes triggering or exacerbating 
a headache. Nicholson et al. (2007) defined negative affect as including emotions, such as 
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anxiety, dysphoria (transient feelings of depression), and anger. Serotonin and gamma-
aminobutyric acid (GABA) have been implicated as a link in the neurochemistry between 
negative affect and headaches. Anxiety is linked to GABA dysregulation. 
Correspondingly, some preventative migraine medications reduce cortical excitability by 
enhancing GABA-ergic function. At a peripheral level, negative affect can lead to 
adrenaline release, sugar infused in the bloodstream, change in blood lipid levels, and 
increases in heart rate, respiration, and muscle tension, any of which alone or in 
combination can instigate a headache.  
The neurotransmitter dopamine also has been implicated in migraine (Sheftell & 
Atlas, 2002). Dopamine plays a role in mood, cognition, aggression, pleasure seeking, 
motivation, impulse control, substance abuse, and aggression. Likewise, migraine 
prodrome symptoms, such as yawning, mood changes, nausea, and vomiting, are treated 
with antidopaminergic medications. Patients with migraine also have an increased density 
of dopamine receptors on peripheral lymphocytes when compared to the density in 
controls, which may reflect an underactive dopaminergic system. In terms of genetics, 
there is evidence that migraine is associated with the dopamine allele ß-hydroxylase. 
Psychological Factors Associated with Headaches 
Depression 
Depression often is associated with the presence of headaches (Nicholson et al., 
2007).  As described by Nicholson et al., (2007), depression is characterized by feelings 
of sadness, despair, emptiness, and/or lack of pleasure in activities that occur almost 
every day for more than 2 weeks. A prospective designed study, measuring the incidence 
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of the first onset of major depression and headaches during a 2-year follow-up study 
found a comorbidity between headache and depression (Breslau, Lipton, Stewart, 
Schultz, & Welch, 2003). There are several hypotheses regarding the relationship 
between the two disorders: (a) there is a shared etiology (whether inherited or acquired), 
thereby creating vulnerability for the development of both disorders; (b) migraine leads to 
worry and dysphoria, thereby increasing the risk for depression; (c) depression leads to 
migraines and/or impairs the ability to cope with pain; and (d) there is a bidirectional 
relationship between depression and migraine, with one disorder increasing the risk for 
the other (Breslau et al., 2003). Much of the following research is aimed at shedding light 
on the relationship between pain and depression. 
Research has not led to a clear understanding about whether there is a shared 
etiology or a bidirectional relationship between depression and headaches (Breslau et al., 
2003). When patients with migraine with and without major depression were compared, 
patients with major depression had headaches at a greater severity but were not at risk for 
headache persistence (Breslau et al., 2003). Likewise, the risk for a first onset of major 
depression increased six-fold with the presence of migraine and a history of one or more 
depressive symptoms (Breslau et al., 2003). However, patients with and without major 
depression did not differ on the frequency of migraine attacks or on the persistence of 
migraine after a 2-year follow-up study (Breslau et al., 2003). Likewise, Breslau et al. 
(2003) found that there was no increase in headache-related disability over time for 
people with persistent migraine and a history of comorbid major depression. 
Interestingly, a correlational study involving inpatient treatment of chronic headache 
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disorders found that reductions in depression scores as measured by the Beck Depression 
Inventory (BDI) were not correlated with a reduction in the frequency of severe headache 
(Hoodin, Brines, Lake, Wilson, & Saper, 2000). Research supporting a bidirectional 
relationship between depression and headaches is conflicting, perhaps because of the 
length of the follow-up period in the studies. 
More definite evidence for the shared etiology hypothesis is found when 
researchers compared patients with migraine with patients with other severe types of 
headache (Breslau et al., 2003). Unlike with migraine, the presence of other severe 
headache disorders did not predict the transition of one or more depressive symptoms to 
the full criteria of major depression (Breslau et al., 2003). Therefore, one can assume that 
the major depression associated with migraine is not simply a reaction of distress from 
pain, because people with severe headaches then also would have depressive symptoms 
transformed into major depression (Breslau et al., 2003).  According to Breslau et al. 
(2003), there is a shared etiology between migraine and depression, which is probably not 
a result of a predisposition to experience or report both physical and psychological 
symptoms of distress. Instead, they propose that the shared etiology is an imbalance of 
hormones or neurotransmitters. Other studies suggest that the shared etiology results from 
a common pathophysiology between both disorders (Cahill & Murphy, 2004). For 
example, both migraine attacks and depressive episodes have a sudden onset, a similar 
course over time, and a partially overlapping treatment responsiveness (Cahill & Murphy, 
2004). 
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Even in the absence of a major depressive disorder, there is a relationship between 
negative affect and headaches (Nicholson et al., 2007). Negative affect can increase the 
likelihood of having a headache, the intensity of pain, and the amount of headache 
disability. Research suggests that sufferers from headache experience more dysphoria as 
compared to people who do not suffer from headache. Likewise, negative affect creates 
more opportunities for stress to trigger a headache. Some studies suggest that negative 
affect increases severity of head pain (Nicholson et al., 2007). The presence of depression 
and dysphoria is a negative treatment indicator. Not only do they negatively influence 
patients’ satisfaction with health care, but in terms of treatment response with general 
medical conditions, depression and dysphoria can interfere with patients’ ability to adapt 
to lifestyle changes, recover from procedures, and adhere to medication regimens 
(Cruess, Minor, Antoni & Millon, 2007; Nicholson et al., 2007). It appears that perhaps 
with some headache types, dysphoria negatively influences the disorder (Nicholson et al., 
2007).  
Researchers analyzed the relationship between mood and pain in experimental 
studies (Keefe, Lumley, Anderson, Lynch, & Carson, 2001). Pain-free participants acted 
roles of positive, negative, or neutral mood states and then engaged in a cold-pressure 
pain tolerance task. Results showed that participants who acted the negative mood state 
showed a significant decrease in cold-pressure pain tolerance. Conversely, participants 
acting the positive mood condition showed a significant increase in cold-pressure pain 
tolerance. Results suggest that negative mood leads to increased reported experimental 
pain and potentially lower pain tolerance. 
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To sort out the relationship between pain and depression, some studies examined 
the effects of a depressive history on pain disorders (Tennen, Affleck, & Zautra, 2006). 
Even years after having a major depressive episode, patients with rheumatoid arthritis 
reported higher levels of pain, as compared to patients without a history of depression. 
However, higher levels of pain were reported only during high levels of distress. 
Likewise, patients with primary fibromyalgia syndrome (PFS) and a history of depression 
vented emotions more and perceived a decline in coping ability with rises in pain, as 
compared to patients with PFS and no history of depression. Interestingly, depressive 
symptoms in patients with PFS in the absence of a history of depression did not impact 
pain significantly unless the patients had a history of depression. However, higher levels 
of depressive symptoms were associated with lower moods on painful days. Patients with 
PFS who were formerly depressed used ineffective coping strategies when pain 
increased. Perhaps previously depressed patients had an erosion of resources and/or a 
vulnerability for using ineffective coping strategies, especially when in pain. 
Another study investigated the relationship between depression and chronic pain 
by looking at the similar and different characteristics of depression and pain and at the 
impact of depression on pain outcomes (Korff & Simon, 1996). Korff and Simon (1996) 
found that not all dimensions of chronic pain are associated with depression. Contrary to 
previously mentioned studies, pain intensity was not significantly associated with 
increased depression. However, Korff and Simon (1996) found that interference with 
activities was a strong predictor of higher levels of depression. Additionally, the number 
of pain days in the previous 6 months combined with the number of pain sites was 
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significantly associated with depressive symptoms. Diffuse pain also was associated with 
increased depressive symptoms. In fact, the combination of diffuse somatic symptoms 
(other than pain) and interference with activities (disability) was associated with 
psychological distress. Korff and Simon (1996) suggested that people reporting diffuse 
somatic symptoms may have a heightened responsiveness to physical and psychological 
stressors. They proposed that the responsivity is related to the same process that creates 
comorbidity between physical and psychological problems. 
Another study found connections among somatic symptoms, depression, and 
headache (Tietjen et. al., 2007). Chronic headache was associated with increased severity 
of somatic symptoms and increased frequency of major depressive disorder. Common 
somatic symptoms other than head pain included extremity/joint pain, back pain, and 
stomach pain. Somatic symptoms that overlapped with depressive symptoms were almost 
twice as likely as pain symptoms for sufferers of chronic headache in the study. Tietjen et 
al. (2007) also found that increases in somatic symptoms were associated with increases 
in depression.  
The interrelationship among somatic symptoms, depression, and headache should 
be interpreted with caution (Tietjen et al., 2007). For example, the increase in depression 
could result from an overlap of similarity between depressive and somatic symptoms 
(Tietjen et al., 2007). Along the same lines, another study found a strong association 
between headaches and somatoform and psychological disorders (Bensenor, Tofoli, & 
Andrade, 2003). Bensenor et al. (2003) attributed the strong association between 
headaches and somatoform disorders to the overlap of similar symptomatology. 
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However, one study suggested that somatic and depressive symptoms are distinct owing 
to the finding that somatic symptoms predicted major depression in the following year 
(Tietjen et al., 2007).  
According to Tietjen et al. (2007), there is probably a synergistic relationship 
between the related variables of depression and headache. For example, while one or two 
pain-related variables may not impact mood, many variables combined may result in 
depression. Tietjen et al. (2007) found that people with frequent headache, severe 
headache-related disability, and multiple somatic symptoms are likely to have active 
major depressive disorder. They also found that as education and income decreased, 
severity of headache frequency, headache impact, somatic symptoms, and depression 
increased. Apparently, rather than a simple, bidirectional relationship between headache 
and depression, there is probably a synergistic relationship between the two variables, 
which may be linked to a dysfunction of the serotonergic system. 
According to Korff and Simon (1996), the associations among diffuse physical 
symptoms, migraines, and depression are the result of a common predisposition between 
migraine and psychological disorders rather than of a causal relationship between the 
disorders. In support against a causal relationship, Korff and Simon (1996) reported that 
people with chronic depression did not have an increased risk for the first onset of back 
pain, stomach pain, or temporomandibular pain, as compared to a control group. 
However, Korff and Simon (1996) did not present research specific to migraine and 
chronic depression.  
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While some research suggests that depression does not increase the risk for 
developing pain disorders, other research suggests that pain may increase the risk for 
developing depression under certain circumstances (Korff & Simon, 1996). Research 
suggests that pain influences depression over time through loss of social reinforcement 
and learned helplessness. However, the length of chronic pain did not predict the onset of 
depression. Rather, unimproved pain predicted the onset of depression. For example, 
after 7 weeks, patients with unimproved back pain were significantly more depressed 
than patients whose pain had improved. According to Koroff and Simon (1996), 
depression seems to manifest as a result of an incomplete recovery, rather than from 
chronicity. Again, Koroff and Simon (1996) did not present research specific to migraine 
and depression.  
Anxiety 
Anxiety and migraine are frequently comorbid disorders, begging the same 
question asked about depression and headache: are they part of the same spectrum or 
separate disorders? (Sheftell & Atlas, 2002). Both disorders sometimes can be treated 
with the same medications, suggesting a related etiology. Likewise, anxiety disorders are 
more prevalent among migraine patients than among the general population. According 
to Sheftell and Atlas (2002), while there is no definite answer, research suggests that 
there are shared mechanisms of action that account for the etiology of anxiety, 
depression, and headaches. 
While research has focused more on the comorbidity between depression and 
headache, anxiety may be even more prominent in patients with headache (Nicholson et 
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al., 2007). Anxiety is defined as worry, fear, uneasiness, and apprehensiveness 
(Nicholson et al., 2007). It can result from real or perceived situations for which 
outcomes are unpredictable, uncontrollable, or unobtainable (Nicholson et al., 2007). 
Anxiety is more chronic during unpredictable events, such as headaches (Sheftell & 
Atlas, 2002). Situations provoking anxiety can be either specific (i.e., a work evaluation) 
or more nebulous (i.e., future career) (Nicholson et al., 2007). Nicholson et al. (2007) 
reported that individuals with headaches have more anxiety than individuals without 
them. Correspondingly, feelings of anxiety and stress are the most common headache 
triggers (Nicholson et al., 2007). Nicholson et al. (2007) reported that anxiety also can 
exacerbate intensity and frequency of head pain. 
Anxiety significantly contributes to headache-related disability (Nicholson et al., 
2007). According to Nash, Williams, Nicholson, and Trask (2006), patients with 
headache and increased anxiety had more disability, a poorer quality of life, and higher 
health care costs than did patients without anxiety. Specifically, one study found that 
pain-related anxiety accounted for about 14% of the variance of headache-related 
disability (Nash et al., 2006). Likewise, even when controlling for pain, headache-control 
beliefs, and emotional distress, physiological anxiety uniquely and significantly 
contributed to disability (Nash et al., 2006). Additionally, less anxiety after a period of 6 
months predicted a lesser impact of headache interference as compared to a reduction of 
headache frequency and medication change (Nicholson et al., 2007).  
Nash et al. (2006) proposed that pain-related anxiety contributes to disability. 
According to the fear avoidance model, pain can trigger cognitive, emotional, and 
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physiological anxiety responses. Pain may trigger cognitions regarding inability to cope, 
activity exacerbating pain, or worry about the inability to complete scheduled activities. 
Pain also may create the physiological responses of anxiety through sympathetic arousal. 
In turn, the psychological and physiological responses of anxiety may create a fear of 
pain, avoidance of activities, and hypervigilance for the preliminary signs of pain.  
Hypervigilance for pain can result from fear of pain, severity of pain, and 
avoidance of pain (Keefe et al., 2001). Fear of pain can lead to avoidance of stimuli that 
may trigger pain, such as movement, social activities, employment, and daily routine 
activities (Keefe et al., 2001). A fear of pain contributed to greater disability and a 
worsening of pain in patients with chronic pain (Keefe et al., 2001; Siedliecki & Good, 
2006). Likewise, one study found that a high fear of pain and severity of pain interfered 
with attention, potentially as a result of hypervigilance for pain (Keefe et al., 2001).  
While research on the relationship between headaches and anxiety sensitivity is in 
its infancy, anxiety sensitivity may increase headache-related disability (Nicholson et al., 
2007). Anxiety sensitivity is a cognitive process defined as the tendency to react fearfully 
to unusual bodily sensations, (i.e., a headache is a brain tumor). The main component of 
AS is the catastrophic interpretation, (thinking the worst about bodily sensations), which 
creates fear. Disability can occur when innocuous sensations misinterpreted as headache 
triggers lead to an avoidance of the specific activities occurring around the sensations 
and/or of activities in general.  
According to Nicholson et al. (2007), anxiety sensitivity also can increase the 
likelihood of precipitating a headache, making headache pain worse. Nicholson et al. 
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(2007) proposed that the negative effects of anxiety sensitivity occur when the 
catastrophic interpretation leads to sympathetic activation, which may trigger head pain 
or precipitate a headache. The increased pain reinforces the catastrophic interpretation, 
thereby increasing sympathetic arousal and consequently perpetuating a vicious cycle that 
may lead to panic attacks (Nicholson et al., 2007). One laboratory study found that 
anxiety sensitivity accounted for higher pain ratings among patients with panic disorder 
as compared to controls (Keefe et al., 2001).  
Some research suggests that fear and anxiety have different relationships with 
pain (Keefe et al., 2001). One study examined the differences. Participants were assigned 
to one of three emotion conditions: fear by a brief shock, anxiety by a threat of shock, 
and a neutral condition. Before and after emotional inductions, participants were tested 
on their pain threshold to radiant heat. Anxiety and fear produced different effects on 
pain threshold as measured by finger withdrawal. Anxiety resulted in increased pain 
reactivity, while fear resulted in decreased pain reactivity. While the results coincide with 
animal-study findings, a previously mentioned study found that fear worsens pain in 
patients with pain. Therefore, more research is needed to determine the role of fear and 
anxiety during the pain process in experimental and naturalistic settings with the general 
population and patients with pain. 
Pain Sensitization 
Negative emotions, such as depression and anxiety, are not only consequences of 
pain but also part of the pain process, particularly the development of pain sensitization 
(Janssen, 2002). Negative emotions serve several functions during the pain process. 
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Avoidance caused by depression or anxiety promotes recovery. Anxiety causes vigilance 
that prevents further harm. However, once pain becomes chronic, negative emotions are 
no longer adaptive. Negative emotions caused by chronic pain may cause ongoing 
physiological reactivity (i.e., enhanced sympathetic activation and muscle tension), along 
with low vagal tone and hypervigilance for pain, contributing to a pain sensitization. In 
turn, pain sensitization causes misdirected attempts to escape or avoid pain, which 
reinforces negative emotions, resulting in functional disability. 
Psychiatric Comorbidity 
With the presence of comorbid psychiatric and medical conditions, health-care 
utilization increases and health perception declines (Kalaydjian & Merikangas, 2008). 
However, psychiatric comorbidity has more of a detrimental effect on the headache 
disorder (Kalaydjian & Merikangas, 2008). Untreated depression may account for some 
pain-treatment failures (Kalaydjian & Merikangas, 2008). Of one study sample, 19 % had 
at least one comorbid psychiatric disorder (Kalaydjian & Merikangas, 2008). Dysthymia 
was the most common comorbid disorder of the depressive disorders, while Generalized 
Anxiety Disorder and Panic Disorder were the most common comorbidities of the anxiety 
disorders (Bensenor et al., 2003; Kalaydjian & Merikangas, 2008). Interestingly, both 
Generalized Anxiety Disorder and Dysthymia are the most chronic disorders in their 
respective categories.  
Suicide is a significant concern among patients with migraine. Cahill and Murphy 
(2004) reported an elevated risk of suicide among patients with Migraine with Aura and 
Migraine without Aura. Of particular risk are patients with Migraine with Aura, with 
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comorbid depressive disorders. For example, with depression alone, the odds of a suicide 
attempt are 7.8 % as compared to 23.2 % for depressive disorders comorbid with 
Migraine with Aura. Even after controlling for psychiatric disorders, both Migraine with 
Aura and Migraine without Aura were significantly associated with suicidal ideation and 
attempts.  
Learned Helplessness 
According to Sheftell and Atlas (2002), helplessness is a psychological state that 
can occur from an uncontrollable situation or a situation perceived as uncontrollable, 
such as headaches. A response pattern of helplessness can lead to a general response of 
learned helplessness, which can contribute to depression and anxiety (Sheftell & Atlas, 
2002). Overmier (2002) reported that learned helplessness is a state resulting from a loss 
of control over one’s environment or over events that are especially noxious or painful. 
Learned helplessness is a state characterized by impaired motivation to initiate coping 
behaviors or learn new ways to cope (Overmier, 2002). A state of learned helplessness 
can last hours, days, or weeks (Overmier, 2002). It is likely to develop when an 
individual is exposed to unpredictable, aversive events outside of one’s control 
(Overmier, 2002). One theory proposed that helplessness is responsible for the 
comorbidity between migraine and psychiatric disorders (Sheftell & Atlas, 2002).  
Stages of Change 
Some studies found that readiness to manage pain, as measured by the Pain Stages 
of Change Questionnaire (PSOCQ), affected treatment outcomes (Hadjistavropoulos & 
Shymkiw, 2007). The precontemplation subscale measures a lack of intention to use self-
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management techniques for pain, while the action subscale measures an active 
engagement in managing pain. Unexpectedly, a high intention to manage pain predicted 
dropout of a 10-session cognitive-behavioral treatment program. However, 
Hadjistavropoulos and Shymkiw (2007) reported that high intention to manage pain and 
high active engagement were associated with less depression and more use of coping 
strategies. Patients who entered treatment with high active engagement and continued to 
increase their engagement early in treatment benefited the most from multidisciplinary 
treatment. Likewise, individuals with high active engagement for managing pain reported 
higher self-efficacy, internal control over pain, and more satisfaction with information 
given by their primary-care provider. 
On the other hand, a low intention to self-manage pain correlated significantly 
with high levels of pain severity, pain-related interference, depression, and pain-related 
anxiety (Hadjistavropoulos & Shymkiw, 2007). Likewise, individuals with low intention 
to self-manage pain reported less control and self-efficacy over pain. Interestingly, 
Hadjistavropoulos and Shymkiw (2007) found that a powerful-others or chance locus of 
control predicted low intention to self-manage pain.  
Headache-treatment outcome studies found psychological indicators for 
medication response and nonresponse (Lucas et al., 2007). Specifically, anxiety and high 
emotional distress, as measured by the Hospital Anxiety and Depression Scale (HAD), 
were associated with a greater likelihood of not responding to medication treatment. 
Lucas et al. (2007) proposed that anxiety and depression play a role in poor medication 
compliance, which contributes to nonresponse to medication treatment. More 
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specifically, they reported that catastrophizing, less use of positive reinterpretation to 
cope, and avoidance were characteristics associated with nonresponders. Interestingly, 
acceptance as a coping strategy also was associated with nonresponders. According to 
Lucas et al. (2007), acceptance may reflect helplessness and unwillingness to take control 
of headaches. On the other hand, it may reflect a transition from seeking treatment to 
adaptation to the disorder. Lucas et al. (2007) also reported that the use of positive 
reinterpretation as a coping strategy was associated with treatment response.  
Neuroticism 
Neuroticism is a personality characteristic associated with maladaptive coping 
skills, the onset of new migraine headache disorder, depression, and other pain-related 
variables (Keefe et al., 2001; Tennen et al., 2006). Neuroticism is defined as the 
disposition to experience and report aversive emotions (Keefe et al., 2001). People with 
high neuroticism may respond to pain in maladaptive ways, particularly with 
catastrophizing (Keefe et al., 2001). One prospective study assessed neuroticism at 
baseline along with the new onset of migraine headaches over a 5-year period. The study 
found that the risk of developing migraine increased directly with neuroticism scores 
among women (Keefe et al., 2001). Therefore, according to Keefe et al. (2001), negative 
emotional states not only are correlated with pain problems, but also are risk factors for 
pain onset and/or exacerbation. Neuroticism also is linked to pain intensity, pain-related 
appraisals, low self-efficacy beliefs, and low pain control appraisals (Hadjistavropoulos 
& Shymkiw, 2007; Tennen et al., 2006).  
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In addition to neuroticism, Huber and Henrich (2003) researched the association 
between personality characteristics and headaches. They found that neuroticism, as 
measured by the neurotic triad on the Minnesota Multiphasic Personality Inventory 
(MMPI-2), and introversion are elevated in patients with migraine. However, headache 
and bodily symptoms are shared items on the neuroticism score, which contributed 
somewhat to elevations. Huber and Henrich (2003) also reported a significant correlation 
between the neuroticism score and headache duration (total time of headaches per week). 
Social conformity also is a personality characteristic associated with patients with 
migraine. Additionally, Huber and Henrich (2003) reported that longitudinal studies 
showed a strong and consistent association between migraines and a stress-reactive 
personality, characterized by nervousness, sensitivity, and tendency to worry. 
Huber and Henrich (2003) reported evidence against trait stability indefinitely 
influencing headaches. According to Huber and Henrich (2003), the elevated introversion 
and neuroticism scores reversed with successful headache treatment. Likewise, the fact 
that stress can trigger the onset of migraines and increase migraine attacks is evidence 
against a “migraine personality.” Instead, Huber and Henrich (2003) proposed an 
interaction between personality and environment. Specifically, the personality traits 
associated with migraine are proposed to result from a lower tolerance to stress, 
ineffective coping strategies, a limited ability to relax, and an increased focus on 
achievement.  
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Stress and Coping 
Appraisals of environmental events can create negative emotional states, which 
can lead to stress (Keefe et al., 2001). Stress is defined as a process of appraisal of events 
and the resources to cope with the events (Keefe et al., 2001). There are two types of 
appraisal: primary appraisal and secondary appraisal (Hassinger, Semenchuk, & O’Brien, 
1999). In primary appraisal, the person determines the significance of the event. In 
secondary appraisal, the person determines available resources (Hassinger et al., 1999). 
The combined primary and secondary appraisals lead to an evaluation of the stress level 
(Hassinger et al., 1999). The appraisal of events can affect the manifestation of the stress 
and the coping efforts used to reduce stress (Hassinger et al., 1999). Additionally, coping 
mechanisms can influence stress-related health symptoms, such as pain (Hassinger et al., 
1999).  
Hassinger et al. (1999) reported that headache sufferers’ appraisal of stress is 
different from the appraisal by headache-free controls (Hassinger et al., 1999). For 
example, those who suffered with headache reported more daily hassles and rated the 
hassles as more distressing and disturbing when compared to the reports and ratings by 
headache-free individuals (Hassinger et al., 1999). Hassinger et al. (1999) proposed that 
when the perception of stress by those who suffer with headache is more negative than 
the typical perception, they may exacerbate their head pain.  
According to Hassinger et al. (1999), headache-free individuals and those with 
tension headache cope with pain differently. For example, Hassinger et al. (1999) 
reported that those with tension headache responded to acute pain with more 
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catastrophizing than that of the control group. Hassinger et al. (1999) also reported that 
those with headache cope with stress less effectively than do controls. According to 
Huber and Henrich (2003), those with headache cope with stress by using coping skills, 
such as wishful thinking, problem avoidance, and self-criticism, which are thought to 
maintain stress rather than to reduce it. Likewise, those with headache use the stress-
reducing coping strategy of social support less frequently than do headache-free controls 
(Hassinger et al., 1999). While there were differences in appraisal of and coping with 
pain among the headache-free, headache, and migraine groups, there were no differences 
among the groups in coping with cognitive stressors (Hassinger et al., 1999).  
Differences in appraisal of and coping with stress were found also between 
patients with migraine and controls, with patients with migraine using maladaptive 
coping skills (Hassinger et al., 1999; Huber & Henrich, 2003). In a laboratory study, 
while patients with migraine reported a cold pressor task as more painful than did 
controls, they did not indicate the experience of pain any sooner than did controls 
(Hassinger et al., 1999). Results suggest that patients with migraine do not have a lower 
pain tolerance to the acute pain task (Hassinger et al., 1999). Hassinger et al. (1999) 
proposed that patients with migraine may have learned to appraise pain as more 
troublesome to lessen responsibility. In clinical studies, patients with migraine used more 
maladaptive coping strategies when dealing with pain and stress, such as catastrophizing 
and social withdrawal (Hassinger et al., 1999). However, in the laboratory study, 
catastrophizing was not found to be a significant reliant coping strategy for patients with 
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migraine. In terms of coping with cognitive stressors, the laboratory study found that 
patients with migraine used wishful thinking and self-criticism (Hassinger et al., 1999).  
There are several possibilities for the relationship between headaches and 
maladaptive coping strategies (Hassinger et al., 1999). One research-based theory 
proposed that using less effective coping strategies to deal with stress and pain can 
exacerbate stress and pain (Hassinger et al., 1999). However, because most studies are 
quasiexperimental, other possibilities have been considered. For example, pain may 
create a mobilization effect to use any coping strategy available, whether adaptive or not 
(Hassinger et al., 1999). Additionally, maladaptive strategies may work for dealing with 
headaches, but could be maladaptive when used in other situations (Hassinger et al., 
1999). Another theory proposed that there is a reciprocal relationship between 
maladaptive coping strategies and headaches, specifically that they both may increase the 
risk for the other to occur (Hassinger et al., 1999).  
Studies show that maladaptive coping strategies and stress are associated with 
poorer adjustment and outcomes for patients with pain (Hassinger et al., 1999). With 
patients suffering from chronic low-back pain and arthritis, catastrophizing predicted 
increased pain levels, psychological distress, and decreased health status (Hassinger et 
al., 1999). Longitudinal studies with patients with rheumatoid arthritis and fibromyalgia 
found that passive coping was associated with depression, psychosocial impairment, and 
increased pain behaviors (Hassinger et al., 1999). Huber and Henrich (2003) reported that 
with patients with migraine, fatigue-induced stress led to longer recovery time from 
tension and depression. According to Hassinger et al. (1999), prolonged stress may lead 
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to an increased comorbidity of depressive and anxiety disorders for patients with 
headache.  
Rothermund and Brandtstädter (2003) conducted research about accommodative 
and assimilative ways of coping with loss of functional deficits. They found that when 
functional impairments presented later in life, compensatory strategies that are 
assimilative in nature, (i.e., obtaining additional resources to avoid losses in order to 
maintain personal standards) increased for individuals up until the age of 70 years, and 
declined thereafter. They proposed that functional impairments initially prompt 
individuals to seek out compensatory strategies. When those strategies are no longer 
efficient in maintaining previous levels of functioning, there is a reduction in their use. 
When compensatory strategies are no longer efficient, self-evaluations become negative. 
However, Rothermund and Brandtstädter (2003) proposed that with accommodative 
coping, the negative effect can be buffered by adjusting personal standards. 
Catastrophizing. Catastrophizing is a maladaptive coping mechanism associated 
with negative pain-related outcomes (Keefe et al., 2001). Despite the negative outcomes, 
this mechanism seems to serve a purpose for patients with pain. Catastrophizing is 
defined as the tendency to focus on and exaggerate pain as a threat and negatively 
evaluate the ability to deal with pain. The coping perspective proposes that people who 
catastrophize may use it to communicate their need for emotional support. Specifically, 
people may catastrophize to elicit the help of others and to reduce future expectations of 
behavioral activity. Catastrophizing is linked to higher self-reported pain, higher levels of 
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overt pain behavior, more pain-related disability, and increased use of pain medication 
and health-care services.  
Kemp, Ersek, and Turner (2005) found associations between demographic 
characteristics and coping strategies for patients with pain. Both female and male older 
adult patients reported that spiritual practice and physical exercise were the most helpful 
coping strategies. Spiritual practice was reported as the third most common pain-coping 
strategy, while regular exercise was reported as the second most common. Religious 
coping strategies for pain management were most commonly reported by women and 
racial minorities.  
Spirituality. In a literature review, Rippentrop (2005) found that patients with 
chronic pain use prayer as one way to cope with pain. In one study of individuals with 
musculoskeletal pain, prayer was the most used nonconventional pain management 
remedy. Another study found that minorities with arthritis used prayer to cope with pain. 
For example, 92% of African Americans and 50% of Hispanics with arthritis used prayer 
to cope with pain. Likewise, a qualitative study of Latina women with arthritis found that 
prayer and religious beliefs or activities were the second most used coping strategies for 
pain.  
While prayer and spirituality are used frequently as coping mechanisms, spiritual 
coping strategies may not be effective ways to cope with pain (Rippentrop, 2005).  Some 
research suggests that prayer characterized by hope is associated with increased pain, 
whereas other research suggests that prayer is associated with reduced pain. Spiritual 
coping is complex, and many coping questionnaires have a religious coping subscale with 
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a few items that capture negative and/or positive effects of religious coping. Some studies 
found no relationship between spirituality and pain. One study found that while 
spirituality religious coping was not associated with quality of life, it was associated with 
positive affect and psychological well-being. For example, spirituality as measured by the 
Spiritual Transcendence Scale, was an independent predictor of positive affect and self-
ratings of health on the Short Form Health Survey (SF-36) in a sample of patients with 
rheumatoid arthritis. 
Social support. For some patients with pain, social support leads to positive 
outcomes, while social isolation leads to negative outcomes (Zautra, Hamilton, & Burke, 
1999). Social isolation predicted greater pain and psychological dysfunction in patients 
with fibromyalgia. For some individuals, social support plays a critical role in the choice 
of coping strategies they use. For example, women with rheumatoid arthritis chose 
coping strategies based on the responses of their social network and personal disposition. 
Women with critical spouses used more maladaptive coping strategies. Older adults with 
negative social relations reported having more difficulty coping with chronic health 
problems. Zautra, Hamilton, and Burke, (1999) reported that positive interpersonal 
interactions may preserve quality of life for individuals with fibromyalgia, while social 
withdrawal during pain episodes may make the individual more vulnerable to stress over 
time. Continual withdrawal from social interaction may weaken the ability to cope 
effectively, thus leading to maladaptive ways of coping. Helping patients with 
fibromyalgia find ways to interact positively with others even during pain attacks can 
improve well-being.  
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Hurwitz, Goldstein, Morgenstern, and Chiang (2006) also reported positive 
effects of social support. In a study of patients with neck pain, those who reported using 
social support and positive self-assurance had less pain and disability 6 months after 
treatment. Patients who had a lack of support from co-workers, family, and friends had 
more symptoms. Likewise, active coping, such as seeking out social support, is 
associated with reduced levels of pain, or no change in pain. On the other hand, passive 
coping, such as social isolation, is associated with high levels of ongoing pain.  
Optimism. Ferreira and Sherman (2007) defined optimism as having a positive 
outlook on life, which is part of one’s temperament and related to adaptation to chronic 
illness. According to Ferreira and Sherman, optimism is related to a better reported 
quality of life and promotes healthier habits and coping with chronic illness. Depending 
on the circumstances of the chronic illness, the role of optimism may vary. For example, 
if the chronic illness can be controlled at least in part by the patient’s behaviors, optimism 
is associated with better functioning. Having positive outcome expectancies predicted 
positive outcomes, such as positive affect, psychological well-being, and the use of 
problem-focused coping strategies.  
Studies show relationships among optimism, pain conditions, and chronic illness 
(Affleck, Tennen, & Apter, 2001; Treharne, Kitas, Lyons, & Booth, 2005). For patients 
in the early stages of rheumatoid arthritis, a chronic, painful arthritic condition, optimism 
was related to less depression, more life satisfaction, and lower levels of pain (Treharne 
et al., 2005). However, when the disease was established, optimism was associated with 
higher pain levels (Treharne et al., 2005). Affleck et al. (2001) reported that patients with 
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rheumatoid arthritis reported more pessimism than optimism being associated with 
negative daily mood, more functional disability, negative daily events, and poorer sleep. 
Individuals who were more optimistic reported having more cognitive coping strategies, 
social support, and control over pain, despite still having pessimistic moments (Affleck et 
al., 2001). Affleck et al. (2001) reported that negative daily experiences, coping 
strategies, and neuroticism in combination with pessimism or optimism affected pain-
related outcomes. Optimists may have better health outcomes because they cope better 
with stress and difficult situations, resulting in less distress and impact on the physical 
condition (Affleck et al., 2001).  
Demographic Factors Associated with Headaches 
Bensenor et al. (2003) reported demographic and psychological factors associated 
with headache. Specifically, they found that headache attributed to psychological factors 
(nervousness or mental illness) peaked for both genders in the 25-34 year age range. 
However, after age 54 year, the frequency of a psychological contribution to headaches 
decreased. Headache attributed to lifestyle and/or physical conditions (i.e., fever, clinical, 
or neurological disorders) or to psychological conditions were 1.5 to 2.9 times more 
common for women than for men (Bensenor et al., 2003). Additionally, the frequency of 
headache problems attributed to lifestyle and/or physical conditions increased with age, 
up until the 55-64 year age range (Bensenor et al., 2003). In 1998, chronic headache 
disorders, such as Chronic Tension Type Headache, Chronic Migraine, and Frequent 
Headache of Other Types, occurred at a median age of 39 years in both men and women 
(Bensenor et al., 2003). Prevalence for Chronic Tension Type Headache, Chronic 
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Migraine, and Frequent Headache of Other Types appeared to be higher for people in 
their 40’s and 50’s and dropped to the lowest levels after age 55 years (Freitag et al., 
2004). Demographic risk factors associated with Chronic Daily Headache include female 
gender; divorced, separated, or widowed marital status; and an education level of less 
than high school graduate (Marmura, Rosen, Abbas & Silberstein, 2009). 
According to Bigal, Liberman, and Lipton (2006), headache disorders change 
with age.  Patients in younger age ranges have a higher proportion of unilateral pain, pain 
aggravated by exercise, photophobia, and phonophobia (Bigal et al., 2006). Moreover, 
with increasing age, migraine attacks are typically less frequent and milder (Bigal et al., 
2006; Kunkel, 2006;). However, while nausea and migraine disability lessen with age, 
total global amnesia and transient migrainous accompaniments are more frequent 
(Kunkel, 2006). Bigal et al. (2006) also found that aura was more common with age. 
With older patients, new-onset migraine is more likely to have secondary causes (Kunkel, 
2006).  
Bigal et al. (2006) reported that the prevalence of headache disorders varies 
among age groups. The peak prevalence of migraine occurred between the ages of 30 to 
39 years (Bigal et al., 2006). Probable Migraine was more common than migraine in the 
younger and older ages (18-29 years; 70+ years) (Bigal et al., 2006). Transformed 
migraine to Chronic Daily Headache was more prevalent in middle- and older-age 
subjects, suggesting that over time some patients transform to Chronic Daily Headache 
(Bigal et al., 2006). Tension-Type Headache is more common before the age of 45 years, 
but it also can occur after the age of 45 years (Bigal et al., 2006). Late-onset Tension- 
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Type Headache is likely caused by excessive muscle tension aggravated by arthritis, poor 
posture, visual abnormalities, and temporomandibular joint disorders (Kunkel, 2006). 
Kunkel (2006) reported that Tension-Type Headache before age 45 years is usually 
associated with depression and stress. 
According to Thorn et al. (2004), there are pain differences between men and 
women. Particularly, women report more intense pain and have a lower threshold for pain 
than men. Thorn et al. reported that there are both biological and psychosocial 
explanations for the gender differences. Catastrophizing and gender roles are two 
psychosocial variables proposed to influence the relationship between gender and pain. 
According to Thorn et al. (2004), gender differences may account for the higher 
prevalence of headache disorders among women.  
According to Thorn et al. (2004), the impact of societal gender roles on 
personality contributes to the pain responsivity differences between genders. They 
defined gender roles as characteristics of gender differences proscribed by society. For 
example, in the United States, stoicism is attributed to men and sensitivity is attributed to 
women. Individuals classified as masculine had higher pain thresholds and significantly 
lower pain-intensity ratings as compared to individuals classified as feminine (Thorn et 
al., 2004).  
Some studies suggest that catastrophizing is a mediator between gender and pain-
related outcomes (Keefe et al., 2001; Thorn et al., 2004). According to Keefe et al. 
(2001), catastrophizing may explain some gender differences of pain reporting. 
Compared to men, female patients with osteoarthritis who catastrophized had higher 
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reported levels of pain, physical disability, and pain behavior (Keefe et al., 2001). 
However, when catastrophizing was controlled for, the gender effects were eliminated 
(Keefe et al., 2001). Contrarily, Thorn et al. (2004) reported that in a cold pressor task, 
catastrophizing measured before the task showed no significant effect on subjective pain 
reports. Likewise, there was only a slight effect from catastrophizing on pain tolerance 
(Thorn et al., 2004). 
The emotional vulnerability trait, which is more prevalent in women, may 
partially explain the gender pain differences (Thorn et al., 2004). Thorn et al. (2004) 
reported that when the emotional vulnerability trait was controlled for statistically, the 
gender differences in pain responses were reduced. Thorn et al. (2004) proposed that the 
emotional vulnerability trait is a mediating link between gender differences, pain 
tolerance, and subjective pain ratings. Interestingly, individuals classified as androgynous 
showed no significant differences in pain ratings as compared to masculine and feminine 
groups. 
Thorn et al. (2004) reported that the emotional vulnerability trait is responsible for 
catastrophizing and the gender differences of pain. When the emotional vulnerability trait 
and the factor of a whiny, complaining attitude were statistically controlled for, men and 
women did not differ in catastrophizing. According to Thorn et al. (2004) catastrophizing 
is likely a characteristic of the emotional vulnerability trait. Therefore, someone with a 
stable pattern of emotional vulnerability may have the tendency to catastrophize in 
response to pain, which is consistent with the stress diathesis model of chronic pain. 
LOS AND INPATIENT HEADACHE UNIT 
 
 
 
48 
According to Thorn et al. (2004), women are more likely than men to develop the 
emotional vulnerability trait as a result of a history of pain and/or negative life events. 
Women are more likely than men to have persistent recurrent pain from chronic nonlife-
threatening conditions. Additionally, the multiple role responsibilities women have may 
lead to greater perceived stress, a higher prevalence of depression, and more negative life 
events in general. However, Thorn et al. (2004) acknowledged that women may become 
more emotionally vulnerable at least partly because of biological predispositions for pain 
sensitivity. 
Minority patients have unique chronic pain experiences (Baker, Buchanan, & 
Corson, 2008). African American people reported more pain and less control over pain 
than reported by Caucasian people. Additionally, African American women are 
disproportionately affected by more chronic medical diseases, rate their health as poor 
more often, and report less functional capacities when compared to Caucasian women. 
The differences between Caucasian and African American women exist even after 
controlling for income and education.  
Baker et al. (2008) examined pain characteristics of a sample of African 
American women aged 61 - 80 years to determine unique pain characteristics. They 
found that women who were younger reported greater pain intensity. Baker et al. 
proposed that the age difference may be related to experience in developing coping skills. 
Older women may have learned better ways to cope with physical or psychological health 
issues. Baker et al. also proposed that older women may have acclimated to higher pain 
thresholds over the years, thereby reducing the perception of pain intensity. The age 
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effect also could have resulted from a cohort effect. For example, the group of older 
women may have had biological vitality or they may have developed psychological 
strength or coping abilities that allowed them to mitigate pain intensity. Baker et al. did 
not report the age range they considered as younger or older.  
Baker et al. (2008) found differences with locus of control (LOC), depression, and 
pain between African American women reported in prior research and other demographic 
populations.  In the sample of African American women aged 61 - 80 years, those who 
experienced greater pain intensity reported more depressive symptoms and an internal 
LOC. In other studies, an internal LOC was related to better pain outcomes, perhaps 
suggesting that LOC functions differently for this sample. Baker et al. (2008) proposed 
that for older African American women, perceived responsibility for pain may create 
self-blame instead of motivation to reduce pain severity. They reported that depressive 
symptoms in this population may be misrepresented. Chronic medical symptoms 
common in the older African American population of women can resemble depressive 
symptoms, making depression difficult to be distinguished from a medical condition.  
Psychological and Medical Factors Associated with Treatment Outcome 
Research has found relationships between treatment outcome and health LOC, 
Medication Overuse Headache, and personality disorders (Lake, Saper, & Hamel, 2009; 
Primavera & Kaiser, 1993). Primavera and Kaiser (1993) found that inpatients with a 
balanced health LOC were discharged an average of 1 day earlier than patients with a 
primary LOC of chance, trust in self, or trust in others. Individuals with a balanced health 
LOC had no extreme differences among health beliefs of chance, trust in self, and trust in 
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others (Primavera & Kaiser, 1993). Lake et al. (2009) found that Medication Overuse 
Headache, particularly from simple analgesics or triptans, was associated with significant 
improvement at discharge from inpatient treatment. Patients least likely to benefit from 
inpatient treatment were those with personality disorders, without Medication Overuse 
Headache (Lake et al., 2009). Inpatients with opioid dependency, which was more 
common among patients with Borderline Personality Disorder (BPD), had a longer LOS 
than the average stay of 13 days. Lake et al.’s (2009) inpatient treatment included 
medical intervention, cognitive-behavioral therapy (CBT), family therapy, relaxation, and 
psychoeducational groups. The majority of the inpatient study population was diagnosed 
with Chronic Daily Headache. Of the study population, 60% were diagnosed with Cluster 
B personality disorders. While Lake et al. (2009) acknowledged that their study was 
neither controlled nor randomized, they retorted that their inpatient population consisted 
of treatment failures, some from respected experts in headache management.  
Lake, Saper and Hamel (2009) described several theories for the relationships 
among negative treatment outcome, BPD, and opioid dependence. One theory is that 
patients with pain and BPD may be more attentive to internally induced pain, rather than 
external pain. Another theory is that patients with pain have deficits in their ability to 
regulate and tolerate distress in order to prevent escalation. Additionally, patients with 
BPD have doctor-patient relationships that are difficult to manage, which may negatively 
affect treatment outcome. Several hypothesized factors may explain the increased rates of 
opioid dependence in inpatients with BPD. Physicians may be more likely to administer 
opioids to patients with BPD because of the patient’s demanding, insistent interactions 
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with physicians. Likewise, patients with BPD may be more likely to request opioids as a 
result of a dysregulation in their pain and affective systems, general emotional distress, a 
need to control relationships, and beliefs of entitlement. Lake et al. (2009) proposed that 
the relationship among the presence of BPD, opioid Medication Overuse Headache, and 
negative outcome in their study may be related to the frequency of substance-abuse 
disorders in individuals with BPD. Specifically, opioids not only may trigger Medication 
Overuse Headache but also may exacerbate psychological symptoms, such as flashbacks, 
dissociation, a feeling of emptiness, and self-injurious behaviors.  
Few studies have been conducted regarding the relationships between inpatient 
treatment outcome and scales as measured on the MMPI-2 and the Millon Behavioral 
Medicine Diagnostic (MBMD) (Diaz, 2004; Grazzi et al., 2002). In a study conducted in 
an inpatient setting with patients with chronic headache, MMPI-2 scales 2, 7, and 8 
predicted LOS (Diaz, 2004). Particularly, scale 8, which measures confusion, 
disorganization, poor judgment, anxiety, and pessimism, predicted a longer LOS. 
Individuals scoring high on scale 8 may lack basic information to problem solve, and 
they may feel socially and emotionally alienated (Butcher et al., 2001; Diaz, 2004). 
Interestingly, individuals with elevations on scale 7 tended to have a shorter LOS (Diaz, 
2004). Scale 7 measures anxiety, tension, insecurity, sadness, pessimism, and fatigue. 
Individuals with elevations on scale 7 also may be meticulous and organized (Butcher et 
al., 2001; Diaz, 2004). They also may worry about social acceptance or have difficulty 
coping with stress (Diaz, 2004). Scale 2, measuring depression, hopelessness, and 
insecurity, also predicted a longer LOS (Diaz, 2004). Individuals scoring high on scale 2 
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may be indecisive, lack self-confidence, or give up easily. Grazzi et al. (2002) found that 
scale 1, which measures concern with physical and bodily complaints, cynicism, and 
pessimism, predicted a negative outcome. Grazzi et al. (2002) reported that findings for 
scales F, 6, and 8 have been difficult to interpret. Diaz (2004) found that the forceful 
scale on the MBMD predicted a longer LOS (Diaz, 2004). Individuals scoring high on the 
forceful scale tend to be domineering, stubborn, and suspicious when interacting with 
others (Diaz, 2004). They also seek out challenges and are often risk-takers.   
Headache Treatments 
Medical 
Headache disorders are treated in a variety of settings: outpatient headache 
centers, inpatient headache units, and emergency departments (Kwiatkowski & 
Alagappan, 2006). According to Kwiatkowski and Alagappan (2006), headache treatment 
in an emergency department may be successful but is often costly and frustrating for 
patients. Outpatient treatment can include medication therapy, nerve blocks, botulinum 
toxins, and nerve blocks (Kwiatkowski & Alagappan, 2006). Inpatient treatment can 
involve any of the previously listed outpatient treatments, along with intravenous therapy 
to break the pain cycle (Kwiatkowski & Alagappan, 2006; Saper, 2008). Inpatient 
therapy is reserved for intractable, severe, or complicated headache disorders 
(Kwiatkowski & Alagappan, 2006; Saper, 2008). 
Preliminary treatment of headache disorders usually involves abortive and 
preventative medication therapy in an outpatient setting (Kwiatkowski & Alagappan, 
2006). Abortive medications are used to limit the intensity and duration of an attack. For 
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mild to moderate attacks, abortives, such as acetaminophen, aspirin, ibuprofen, naproxen 
sodium, and tolfenamic acid, are suggested. For moderate to severe attacks, abortives, 
including dihydroergotamine, triptans, prochlorperazine, metoclopramide, ketorolac, and 
meperidine are suggested, some of which are administered intravenously or 
intramuscularly.  
Preventative medications are used to decrease the intensity and frequency of 
attacks (Kwiatkowski & Alagappan, 2006). Preventative medications are used when there 
are more than two to three attacks a month, attacks last longer than 48 hours, or attacks 
are severe or debilitating. Preventative medications are usually 55 - 65% effective but 
have significant side effects. Therefore, when headaches decrease, tapering and 
discontinuing the preventative medication is recommended. Preventative medications 
include β-adrenergic blocking agents; calcium channel blockers; tricyclic antidepressants; 
anticonvulsants, such as divalproex sodium and sodium valproate; monoamine oxidase 
inhibitors; and methysergide. 
Intractable, severe, or complicated headache disorders are best treated in an 
inpatient setting (Kwiatkowski & Alagappan, 2006; Saper, 2008). If aggressive outpatient 
or emergency department treatment is not effective, inpatient treatment is recommended 
(Saper, 2008). Specifically, inpatient treatment is necessary when detoxification is 
needed, when the presence of comorbid medical or psychological disorders interferes 
with treatment efficacy, or when unstable vital signs or dehydration is present (Saper, 
2008). If not already completed, the preliminary steps of inpatient treatment involve 
laboratory and imaging tests to rule out headaches caused by secondary conditions 
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(Saper, 2008). Next, patients are given intravenous fluids and medications to break the 
pain cycle (Saper, 2008). If present, Medication Overuse Headache is treated by 
reduction of the overused drug while controlling withdrawal symptoms (Saper, 2008). 
Psychological assessment is offered early during inpatient treatment, followed by 
corresponding psychological treatment (Saper, 2008). Preventative and abortive 
medications may be tried experimentally with in order to establish an outpatient regimen 
offering more headache control (Saper, 2008).  
Psychological 
 Psychological treatments for headache can influence the course and outcome of 
headache disorders (Sheftell & Atlas, 2002). Psychological treatments complement the 
efficacy of pharmacological treatments (Sheftell & Atlas, 2002). Treatments include 
emotional disclosure, CBT, for stress management, relaxation, biofeedback, and patient 
education. 
Emotional disclosure. The negative effects of emotional inhibition on physical 
symptoms have led to the development of therapeutic interventions to increase emotional 
awareness (Keefe et al., 2001). For example, Keefe et al. (2001) described a treatment 
used to increase awareness of emotions and the relationship between physical symptoms 
and emotions. While the treatment has not been tested in controlled treatment outcome 
studies, according to Keefe et al. (2001), one study found that participants showed a 
reduction in symptoms (less temporomandibular joint pain or low back pain) and a 
greater awareness of emotions. 
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 Emotional disclosure has varying outcomes, both positive and negative (Keefe et 
al., 2001). Treatment during which intense emotion was elicited with gestalt techniques 
reduced symptoms of depression but did not reduce long-term pain (Keefe et al., 2001). 
While pain levels were lower after sessions, the average pain level of patients increased 
between sessions (Keefe et al., 2001). Another approach that may be better suited for 
patients with pain is disclosure of troubling emotions at the patient’s own pace (Keefe et 
al., 2001). Patients can be encouraged to write about stressful experiences in a self-
directed and self-paced manner in order to avoid symptom exacerbation (Keefe et al., 
2001). Overall, according to Keefe et al. (2001), emotional disclosure seems to result in 
short-term distress but long-term improvement taking several months. 
 Emotional disclosure has shown mostly positive effects for patients with 
rheumatoid arthritis (Keefe et al., 2001). Keefe et al. (2001) described one study that 
found that patients with rheumatoid arthritis reported significantly less affective 
disturbance and improved ability to conduct daily activities after 3 months of disclosure 
about stressful experiences. Although patients reported increased negative mood after 
verbal disclosure, they had the most improvement in their joint condition after 3 months 
as determined by a physician examination and physical tests. Patients with rheumatoid 
arthritis participating in emotional disclosure also had objective health improvements. 
Patients who wrote for 3 days about stressful experiences had significantly lower global 
impairment scores after 4 months as compared to those of controls, as assessed by 
physicians who were blind to groups.  
LOS AND INPATIENT HEADACHE UNIT 
 
 
 
56 
According to Keefe et al. (2001), patients with rheumatoid arthritis are not the 
only individuals who can benefit from emotional disclosure. College students and healthy 
people in the community experienced health benefits by expressing emotions through 
private writing or verbal disclosure. Decreased health-care visits, enhanced 
immunological response, improved grade-point average, and faster reemployment after 
being laid off were some positive benefits. Emotional disclosure also may help 
individuals who catastrophize about dental procedures. Patients who participated in 
emotional disclosure and scored high on catastrophizing reported less pain and better 
mood than participants who scored high on catastrophizing and were in the control group.  
 Along with the emotional component of emotional disclosure, physiological and 
cognitive mechanisms are involved (Keefe et al., 2001). Venting emotions may decrease 
pain by changing the physiology that contributes to pain. Keefe et al. (2001) proposed 
that emotional processing activates the emotional schema, leading to cognitive changes. 
Emotional disclosure creates disconfirming evidence when negative affective states do 
not lead to harm. Additionally, repeated disclosure creates habituation to negative 
affective states. However, emotional catharsis in itself, without cognitive change, seems 
to be counterproductive.  
CBT. CBT can help patients with headache cope better with everyday stresses that 
may trigger, exacerbate, or maintain headaches (Penzien et al., 2005). CBT helps patients 
identify cognitive and affective components of the stress response and understand the 
relationship among headaches, stress, and coping ability. Patients are guided to find the 
cognitive, emotive, and behavioral triggers of headaches and use more effective strategies 
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to deal with headache-related stress. For example, patients often respond to a debilitating 
headache condition with depression or anxiety, which CBT can reduce. CBT is used 
often in conjunction with relaxation techniques and biofeedback. 
More specifically, CBT can be helpful for psychological problems, such as low 
self-efficacy, low internal LOC, or anxiety that can make managing headaches difficult 
(Nicholson et al., 2007). Patients may think they have no influence on headache attacks 
(low internal LOC) or that they are not able to manage headache triggers (low self-
efficacy). Educating patients about ways to manage headache triggers to reduce the 
number of headache attacks and about their role in managing triggers can increase 
internal LOC. In addition, socratic questioning can be helpful for patients with anxiety-
related disability who have catastrophic fears. For example, therapists can guide patients 
who limit their activity because of fear of provoking a headache to find instances when 
activity did not result in debilitating headaches or when medications aborted the 
headache. 
Relaxation and biofeedback. Relaxation techniques and biofeedback involve the 
practice of controlling physiological responses that contribute to headaches (Penzien et 
al., 2005). Relaxation training and biofeedback can help patients gain better control over 
headache-related physiology in general by lowering sympathetic arousal. Relaxation is 
taught as a headache preventative, not an abortive. Practice is emphasized before seeing 
results, as training may take as many as 10 sessions. Three types of relaxation training are 
widely used—progressive muscle relaxation, autogenic training, and mindfulness. 
Progressive muscle relaxation involves alternating between tensing and relaxing muscles; 
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autogenic training involves using heaviness and warmth; and mindfulness involves 
calming the mind by maintaining focus on repeating words.  
Biofeedback is the practice of controlling physiological responses, such as skin 
temperature and muscle tension (Penzien et al., 2005). Patients are taught to warm finger 
temperature and/or reduce arousal and muscle tension (Penzien et al., 2005). They are 
provided feedback on their performance through sensors that detect their physiological 
responses (Holroyd et al., 1984). Relaxation is usually a main component of biofeedback 
(Penzien et al., 2005). Like relaxation training, biofeedback is a preventative treatment 
that must be practiced at home regularly to be effective (Penzien et al., 2005).  
Outcomes of relaxation and biofeedback practice vary, depending on the research 
(Freitag et al., 2004; Grazzi et al., 2002; Holroyd et al., 1984; Hoodin et al., 2000). 
According to Holroyd et al. (1984), successful performance feedback was associated with 
headache reduction. Holroyd et al. (1984) proposed that successful performance feedback 
leads to cognitive changes in self-efficacy and LOC, which are both associated with 
headache reductions. Freitag et al. (2004) reported that patients who practiced relaxation 
more frequently during severe headaches and to prevent headaches showed the greatest 
decrease on the Beck Depression Inventory (BDI) at discharge during inpatient treatment. 
The change in BDI scores was correlated with the frequency of relaxation practice 
(Freitag et al., 2004). However, there was no significant correlation between BDI changes 
and reduction of severe headache. Grazzi et al. (2002) reported that during inpatient 
treatment, patients who received biofeedback and relaxation training in conjunction with 
pharmacologic intervention experienced a clear advantage from treatment over a 3 year 
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period, as compared to patients receiving only pharmacologic intervention. Levels of 
improvement for the combined treatment group remained the same at posttreatment 
(Grazzi et al., 2002). Likewise, the relapse rate was significantly lower in the combined 
group at 3 years (Grazzi et al., 2002). Patients receiving the combined group treatment 
were also more careful in their use of analgesic medications (Grazzi et al., 2002). 
According to Hoodin et al. (2000), the practice of relaxation during inpatient medical 
intervention was associated with decreased depression as measured by BDI scores. 
Hoodin et al. (2000) proposed that an internal health LOC may have contributed to the 
increased adherence to relaxation practice and that treatment gains may have contributed 
to the decrease in depression.  
Patient education. Patient education can help patients to manage headache 
episodes, become independent with self-care, initiate activities to manage headaches, 
manage medical therapies better, and alter daily routines to manage headaches (Sheftell 
& Atlas, 2002). Education should help patients understand how the underlying biology of 
the headache disorder is influenced by triggers, such as diet, hormones, environmental 
changes, sensory stimuli, and stress (Sheftell & Atlas, 2002). Likewise, teaching patients 
about the functions of abortive and preventative medications can help patients become 
more involved in their treatment plan (Sheftell & Atlas, 2002). Patient education can be 
used to improve medication compliance, especially for patients who have low self-
efficacy for taking medication (Nicholson et al., 2007). Providers should discuss barriers 
to adherence and give reinforcement for adherence in order to increase self-efficacy and 
medication compliance (Nicholson et al., 2007).  
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Chapter Three: Hypotheses 
The purpose of this study is to predict a longer LOS and minimal improvement by 
regressing LOS and minimal improvement on a number of psychological variables as 
measured on the MBMD (Millon, Antoni, Millon, Minor, & Grossman, 2006). LOS is 
measured by the difference between the admission and discharge dates. Both the 
admission and discharge dates are included in the calculation of the LOS. Minimal 
improvement is measured by the difference between admission and discharge scores on 
the Brief Pain Inventory-Short Form (BPI-SF; Cleeland, 2009) interference and severity 
scales and the difference between preadmission headache index scores and discharge 
headache index scores. The headache index score assesses frequency, duration, and 
severity of headaches. 
Hypothesis 1 
Ho: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a 
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual 
absence) does not significantly and independently predict a longer LOS. 
H1: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a 
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual 
absence) significantly and independently predicts a longer LOS. 
Hypothesis 2 
Ho: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a 
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual 
absence) does not significantly and independently predict minimal improvement. 
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H2: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a 
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual 
absence) significantly and independently predicts minimal improvement. 
Hypothesis 3 
Ho: After inpatient treatment, there was not a significant difference between 
admission and discharge BPI-SF interference scores.  
H3: After inpatient treatment, there was a significant difference between 
admission and discharge BPI-SF interference scores.  
Hypothesis 4 
Ho: After inpatient treatment, there was not a significant difference between 
admission and discharge BPI-SF severity scores.  
H4: After inpatient treatment, there was a significant difference between 
admission and discharge BPI-SF severity scores.  
Rationale 
Psychological factors, such as depression, anxiety, personality traits, and 
maladaptive coping skills, can complicate headache disorders. Individuals with comorbid 
depression experienced more disability from migraine headaches than individuals without 
comorbid depression (Breslau et al., 2003). Likewise, depression is a risk factor for 
increasing the likelihood of the onset of pain and/or the exacerbation of pain (Keefe et al., 
2001). With medical conditions in general, depression and dysphoria are obstacles for 
some patients attempting to adapt to lifestyle changes, recover from procedures, and 
adhere to medication regimens (Cruess et al., 2007). According to Nash et al. (2006), 
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patients with headache and increased anxiety have more disability, a poorer quality of 
life, and higher health-care costs than those without increased anxiety. Pain sensitization 
causes misdirected attempts to escape or avoid pain, which reinforces negative emotions, 
resulting in functional disability (Janssen, 2002). Social isolation predicted greater pain 
and psychological dysfunction in patients with fibromyalgia (Zautra et al., 1999). 
According to Ferreira and Sherman (2007), there are relationships between improved 
psychosocial and physical-health outcomes and optimism. Rippentrop (2005) found that 
spirituality was an independent predictor of positive affect in a sample of patients with 
rheumatoid arthritis. This author is assuming that the psychological factors discussed in 
the literature review that complicate the headache disorder will lead to a longer LOS 
and/or minimal improvement. Likewise, discovering whether this study replicates the 
results found by Diaz (2004), that the forceful scale on the MBMD predicted a longer 
LOS, would be beneficial.  
Hypotheses 3 and 4 regarding the efficacy of inpatient treatment as measured by 
the BPI-SF were proposed in order to confirm minimal improvement as a valid, accurate 
construct in reference to the inpatient treatment provided. For example, if inpatient 
treatment was not effective for the majority of inpatients, the ability of the proposed 
psychological variables to predict minimal improvement would be skewed. However, the 
efficacy of inpatient treatment was not the focus of this study. Therefore, experimental 
controls were not implemented for treatment-efficacy hypotheses.  
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Chapter Four: Methods 
This quasi-experimental, prospective, cross-sectional, survey research study used 
multiple regression to predict psychological factors associated with a longer LOS and 
minimal improvement in a headache inpatient unit. Survey research is the most efficient 
way to collect data for this study. It is the least obstructive and time-consuming method 
for patients. Collecting data prospectively avoided recall errors that patients may have 
had if they had been required to rely on their memory.  
Study Overview 
This study was conducted at the Jefferson Headache Center at Methodist Hospital 
between the months of August 2010 and May 2011. The headache inpatient unit at 
Methodist Hospital practices an interdisciplinary-team approach composed of attending 
physicians, the nurse coordinator, a headache fellow, a neurology resident, a 
psychologist, a psychiatrist, unit nurses, and a physician assistant, all of whom coordinate 
care. As a standard of care, patients must have a neurological evaluation before 
admission to rule out causes of pain other than headache. All patients are diagnosed with 
a headache condition within the standards of the International Headache Society before 
admission. As a part of the inpatient admission process, patients are required to complete 
a calendar to record their headache frequency, severity, and duration for at least 1 week 
before planned admission.  
Assuming two-tailed α = 0.05 and power = 0.95, a sample of 153 patients would 
allow a determination of whether the seven hypothesized psychological factors predict 
minimal treatment outcome and a longer LOS (Faul, Erdfelder, Buchner, & Lang, 2009). 
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The headache center at Methodist averages 10-13 inpatients a week. Recruitment was 
estimated to take approximately 4 to 8 months. However, glitches with recruitment 
precluded following the planned schedule. From August 2010 through October 2010, key 
personnel tried to increase the response rate of the preadmission calendars used to obtain 
baseline headache index scores. At the start of collecting data in August, key personnel 
realized that calendars were not being included in the inpatient packets mailed to patients 
prior to planned admissions. Likewise, about half of inpatients were admitted on an 
emergency basis, precluding the possibility of completing the preadmission calendar 
during the week before admission. As a result, staff circulated calendars, encouraging all 
patients to complete a calendar on a daily basis and to bring the calendar when admitted 
for inpatient treatment. Data collection resumed in November despite the continued poor 
response rate of preadmission calendars. Study procedures were not changed as a result 
of the poor response rate because reliable outcome measures, such as LOS and BPI-SF, 
were being collected as well. Preadmission calendars continued to be collected from 
participants who had them. Consenting inpatients were included regardless of whether 
they had the preadmission calendar.  
Data collection outcome 
By the end of May 2011, there was a total of 87 consenting participants. 
Approximately two to four inpatients consented to the study each week. Several factors 
could have attributed to the difficulty of amassing consenting participants in the numbers 
as estimated. Many patients were sleeping or in pain during the consenting opportunities. 
Additionally, some patients declined because they had visitors at the time. Some patients 
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declined because they reported that they did not have the cognitive ability to complete the 
surveys. There were 36 participants who did not complete the discharge BPI-SF for 
several reasons. Some patients did not complete the discharge BPI-SF because they 
refused or did not stay for the entirety of treatment as recommended. However, a majority 
of the discharge BPI-SF forms were not completed because of communication issues 
between key personnel and headache center inpatient staff. 
Inclusion criteria 
Patients admitted into the headache inpatient unit between November 2010 and 
May 2011 were approached with opportunities to consent to being a participant in the 
study. Participants were 18 years or older. Individuals younger than the age of 18 years 
are not admitted into this inpatient unit. In order to be included in the study, patients were 
required to have had the headache disorder for 3 or more months, demonstrate the ability 
to consent, complete measures at admission and discharge, and complete the entire stay 
as recommended. 
Exclusion criteria  
Patients with the following characteristics were excluded from the study: patients 
who had a cluster headache disorder, did not speak and read English, were not able to 
consent, failed to complete measures at both admission and discharge, left early against 
recommendations because of insurance or personal reasons, and did not have the 
headache disorder for 3 or more months.  
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Consent process 
Key personnel visited new patients no longer than 1 day after admission and 
asked several questions in order to assess the patients’ ability to consent. Patients were 
asked questions to determine whether they spoke and read English and were oriented to 
date, time, place, and persons. Patients were visited again at a later date if they were 
unable to consent because of sleep, fatigue, and/or disorientation during the initial 
attempt.  
Upon meeting initial inclusion criteria of speaking English and having the ability 
to consent, key personnel briefly explained the purpose of the study and the consent 
process to patients. Key personnel reviewed the risks and benefits and emphasized that 
participation was voluntary, did not affect care, and could be withdrawn at any time 
without any consequences. Patients were given as much time as needed to read the 
informed consent, ask questions about the study, and consent or decline. After providing 
written informed consent, key personnel reviewed patients’ records to ensure that they 
met the additional inclusion criteria (having the headache disorder for 3 or more months, 
no cluster headache diagnosis) and ensured that the patient planned to stay for the entirety 
of treatment. Patients who did not meet inclusion criteria were notified of the reason they 
could not participate. A copy of the informed consent was kept in a separate file for 
patients who qualified. The consent forms for those who did not qualify were shredded.  
Procedures 
Key personnel gave patients who consented and met inclusion criteria a copy of 
their signed informed consent, the MBMD, the BPI-SF, the calendar to complete during 
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the stay, and a demographic profile created for this study. The demographic questionnaire 
included questions about age, gender, race, education level, and work status. The 
admission measures typically took 60 minutes to complete. While patients had as long as 
90 minutes to complete the measures, arrangements were made to accommodate patients 
who needed more time. Key personnel picked up the measures after 90 minutes or at a 
later date if more time was needed. No sooner than 1 day before discharge, patients were 
given the BPI-SF again, which typically took 5 minutes to complete.  
After completion of admission and discharge measures, the patient’s name, dates 
of admission and discharge, LOS, and medical and psychiatric diagnoses were recorded 
on a form labeled, “Patient Information.” Medical and psychiatric diagnoses were 
obtained from the current inpatient hospital records and recorded on the Patient 
Information form. Additional survey data (MBMD, admission and discharge BPI-SF, 
preadmission and discharge headache index score) were matched with the patient 
information data and entered on a spreadsheet. The spreadsheet file was password 
protected. Upon completion of the study, the file was deleted and survey data were 
shredded. Until completion of the study, survey data were secured in a locked filing 
cabinet kept on site. While names were collected, they were neither reported nor 
published.  
Measures 
MBMD. The MBMD (Millon et al., 2006) is a self-report measure developed to 
reflect the attitudes, behaviors, and concerns of medical patients. It measures factors such 
as psychiatric indicators, coping styles, stress moderators, treatment prognostics, and 
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management guides (Cruess et al., 2007). Three scales, Debasement, Desirability, and 
Disclosure, are designed to correct for response patterns that may distort scores (Cruess et 
al., 2007). The measure includes 165 true-false items, estimated to take approximately 
20-25 minutes to complete (Cruess et al., 2007). The MBMD was normed on more than 
700 patients, from the age range of 18 to 85 years, with medical conditions, such as heart 
disease, cancer, diabetes, chronic pain, and HIV/AIDS (Cruess et al., 2007). The MBMD 
demonstrates both internal reliability and consistency, with an internal consistency 
coefficient mean of α = .79 for all scales and a test-retest reliability mean of .83 for all 
scales (Cruess et al., 2007). With convergent validity, the MBMD depression scale 
correlated at .87 with the BDI. Prevalence scores reflect a comparison to the normed 
population (Cruess et al., 2007). Of the coping styles, a prevalence score of 60 or higher 
should be considered in analyses (Millon et al., 2006). Of the psychiatric indicators, a 
prevalence score of 75 - 84 suggests the presence of the scale’s disorder, while a 
prevalence score of 85 and higher suggests a prominence of the scale’s disorder (Millon 
et al., 2006).  Prevalence scores between 60 and 74 are suggestive of the presence of 
symptom pathology but not sufficiently indicative unless the score is the highest score of 
the psychiatric indicators (Millon et al., 2006).  
For this study, the scales analyzed will be a) anxiety-tension and depression from 
the psychiatric indicators, b) forceful coping style, and c) pain sensitization, social 
isolation, future pessimism, and spiritual absence from the stress moderator scales. For all 
categories of scales, this study included scores of 60 or higher in analyses. Items on the 
anxiety-tension scale include “I’m on edge a lot lately” and “I feel jumpy and under 
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strain, but I don’t know why” (Millon et al., 2006). The depression scale measures poor 
appetite, social withdrawal, discouragement, guilt, behavioral apathy, self-depreciation, 
and anhedonia. The forceful scale measures domineering, tough-minded, and distrustful 
characteristics. The pain sensitization scale measures the tendency to be overly sensitive 
and reactive to pain. The social isolation scale measures perception of social support. The 
future pessimism scale measures outlook towards health status. The spiritual absence 
scale measures spiritual or religious resources to cope with stress, fear, or uncertainties 
associated with medical conditions.   
Headache index score. The headache index score measures headache frequency, 
duration, and severity. A calendar with an intensity scale will obtain frequency, duration, 
and severity of headaches. The headache index score was calculated by multiplying each 
day’s average intensity, by duration of headache in hours for that day, adding the week’s 
total multiplications of hours and intensity, and dividing by the total number of days. 
Intensity is measured on a scale from 0 (no pain) to 10 (the worst pain you can imagine). 
Outcome was determined by the difference between preadmission and discharge 
headache index scores. The higher the difference, the better the outcome. Zero indicated 
no change from treatment. A negative difference indicated a regression from the 
admission condition. 
BPI-SF. The BPI-SF is a widely used self-report measure to assess clinical pain 
(Cleeland, 2009). The BPI-SF is composed of two factors: severity and interference. The 
interference factor has two subdimensions, an affective subdimension and an activity 
subdimension. The affective subdimension measures pain interference in reference to 
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relationships, enjoyment of life, and mood. The activity subdimension measures pain 
interference in reference to walking, general activity, and work. A five-option verbal 
descriptor scale, with ratings of 0 = not at all, 1 = a little bit,  2 = moderately, 3 = quite a 
bit, and 4 = extremely, is used to measure pain interference. Pain severity is assessed by 
asking questions about pain over time: at its “worst,” “least,” “average,” and “now.” The 
recall period of the severity and interference scale is a week. A numerical rating scale is 
used to measure pain severity, where 0 = no pain and 10 = worst pain you can imagine. 
For this study, outcome was determined by the differences between admission and 
discharge interference and severity scores. The higher the difference, the better the 
outcome. Zero indicates no change from treatment. A negative difference indicates a 
regression from the admission condition. 
Factor analysis in a large outpatient metastatic cancer study (N = 1,261) verified 
the two separate factors of pain severity and interference. In the same study, internal 
stability was good, ranging from .80 to .87 for the four pain severity items and .89 to .92 
for the seven interference items. Multidimensional scaling provided strong psychometric 
support for the independent measurement of pain interference and severity. Initial short-
term (1 day to 1 week) test-retest reliability for ratings of “worst,” and “average,” pain 
severity was acceptable (.78). Test-retest reliability for pain “now” is less (.59). Several 
more recent studies found similar test-retest coefficients. An outpatient German pain 
clinic study with retest occurring 30-60 minutes after the first administration found 
coefficients of .98 for pain severity and .97 for pain interference. Reliability coefficients 
for daily administration of pain severity “worst” “average” and “current” ranged from .83 
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to .88. Test-retest reliabilities for pain interference in the same study ranged from .83 to 
.93. 
Analysis of Risk and Benefits 
While patients in the study will not directly benefit from participation, the study 
may help future patients by providing data potentially to implement programs and/or 
procedures aimed to ameliorate factors associated with a longer LOS and minimal 
improvement. New programs and/or procedures aimed at specialized care could lower 
costs incurred by headache both to patients and society. There is a rare risk that patients 
may experience psychological distress from completing the measures. In the case that 
patients experience distress, psychological support is available on the unit to remediate 
the situation. 
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Chapter Five: Results 
Data Collection Outcome 
The difference between preadmission and discharge headache index scores was 
not used as a criterion variable because of the low response rate of the preadmission 
calendar. The response rate for the preadmission calendar used to obtain baseline 
headache index scores was only 6.9% among consenting participants. Of the 87 
consenting participants, 36 were lost owing to failure to obtain discharge data, leaving a 
total of 51 completed protocols (see Table 1 for specific demographic information of 
consenting participants). Of the sample population, 78% was age 35 years and older. For 
analyses purposes, adults aged 18 to 34 years and adults aged 35 years and older were 
coded into two separate categories.  
 
 
Table 1 
Demographics of Consenting Participants 
Gender Hispanic  African American Caucasian 
Female       3             4        71 
Male       0             1         8 
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Analyses and Results for Hypotheses 1 and 2 
A multiple linear regression analysis was performed to determine the proportion 
of variance accounted for by the model, the significance of the model, and the 
significance of the predictor variables to predict the criterion variables (LOS and minimal 
improvement as measured by BPI-SF interference and severity differences scores). The 
model included the following scales: anxiety-tension, depression, forceful coping style, 
pain sensitization, social isolation, future pessimism, and spiritual absence. Using the 
simultaneous “enter” method on SPSS, version 19.0, all seven predictor variables in the 
model were entered in three separate analyses for each criterion variable. The proportion 
of the variance accounted for by the hypothesized model to predict each criterion variable 
(LOS and minimal improvement as measured by BPI-SF interference and severity 
difference scores) was not significant (see Table 2). Specifically, hypothesis 1, stating  
 
 
Table 2 
Significance of Hypothesized Model to Predict LOS and Minimal Improvement 
Dependent Variables R Square       F      Adjusted R   
LOS    .034   .219  -.123   
Severity     .089   .601  -.059   
Interference    .170 1.256         .035   
Note. Model 1 predictors: Pain Sensitization, Depression, Anxiety, Social Isolation, Spiritual Absence, 
Pessimism, Forceful Coping Style. Severity and Interference scores are measured by the Brief Pain 
Inventory (Short Form). LOS= length of stay. 
p < .05.  
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that the model predicted a longer LOS, was not supported. Hypothesis 2, stating that the 
model predicted minimal improvement also was not supported. Additionally, there were 
no significant correlations between individual predictors of the model and each criterion 
variable.  
Exploratory Analyses and Results 
As observed during data review, a majority of the sample had elevations on the 
Pessimism and Pain Sensitization scales (see Table 3). Likewise, a pattern emerged 
among the refractory cases. A case was determined refractory when there was a LOS of 8 
days or longer and BPI-SF interference or severity scores were less than or equal to 1.5. 
The refractory criteria were determined based on review of the outcome means (see Table 
4 for means and standard deviations of outcome variables). Nonmarried participants with 
low Confident and Sociable scores and a high Denigrated score on the MBMD coping 
skills scales were observed to have minimal improvement after inpatient treatment in this 
sample population (see Table 5 for sample percentages of elevations and absences of 
elevations of exploratory variables). Marital status was coded as either married or not 
married. Participants labeled single, divorced, or separated were coded as not married for 
analyses purposes. Supplemental analyses were conducted using two exploratory models 
based on the aforementioned findings. Predictors of the first exploratory model included 
marital status and denigrated coping style. Predictors of the second exploratory model 
included sociable and confident coping styles. Only two predictors were included in each 
exploratory model because of the small sample size in order to increase the chances of 
detecting significance. Using the simultaneous “enter” method on SPSS, version 19.0, 
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predictor variables in the models were entered in three separate analyses for each 
criterion variable. The proportions of variance accounted for by the exploratory models 
 
 
Table 3 
Percentages of Inpatients with Elevations on Predictor Variables 
Forceful 
coping 
style 
Depression Pain  
sensitization 
Anxiety Spiritual  
absence 
Social  
isolation 
Pessimism 
8        69       94      59     31     37        84 
Note. n = 51. Decimals rounded to whole numbers. Prevalence score ≥ 60.  
 
 
Table 4 
Mean and Standard Deviation of LOS, BPI-SF Severity, and Interference Difference 
Scores 
Dependent Variables Mean Standard deviation 
LOS 
BPI-SF interference score 
BPI-SF severity score  
 7.29 
 3.29 
 3.39 
           2.11 
           2.75 
           2.26 
Note. n = 51. Decimals rounded to tens place. LOS = length of stay; BPI-SF = Brief Pain Inventory (Short 
Form). 
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Table 5 
Percentages of Inpatients with Elevations and Absences of Elevations on Exploratory 
Predictors in Supplemental Analyses 
Denigrated Sociable Confident Not married 
       63      63      69        39 
Note. n = 51. Denigrated, Sociable, and Confident are coping skills scales on the Millon Behavioral 
Medicine Diagnostic. Decimals rounded to whole numbers. Sociable and Confident scales percentages 
represent an absence of elevation. 
 
 
to predict each criterion variable (LOS and minimal improvement as measured by BPI-SF 
interference and severity difference scores) were not significant (see Tables 6 and 7).  
Owing to the high percentage of older adults in the population sample, 
exploratory analyses were conducted on the disabled status collected on the demographic 
questionnaire and the outcome variables. Participants had the following options on the 
demographic questionnaire regarding work status: employed part-time or full-time, 
student, unemployed, or disabled. For analyses purposes, disabled status was coded into 
two categories, disabled and not disabled. Any category other than disabled was 
considered not disabled. On the demographic questionnaire, the disabled category did not 
specify whether someone was receiving public assistance. A Pearsons r bivariate 
correlation was conducted using SPSS, version 19.0, to determine correlation between the 
disabled category and each outcome variable (LOS and minimal improvement as 
measured by BPI-SF interference and severity difference scores). There were no 
correlations between the disabled category and the outcome variables (see Table 8).  
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Table 6 
Significance of Exploratory Model of Marital Status and Denigrated Coping Style to 
Predict LOS and Minimal improvement 
Dependent 
Variables 
R  Square     F Adjusted R 
LOS 
Severity  
Interference 
   .231 
   .093 
   .077 
1.348 
  .208 
  .143 
      .014 
     -.033 
     -.036 
Note. Exploratory model predictors: Married Marital Status and Denigrated Coping Style. Severity and 
Interference scores are measured by the Brief Pain Inventory Short - Form. LOS = length of stay. 
p < .05. 
 
 
 
Table 7 
Significance of Exploratory Model of Sociable and Confident Coping Styles to Predict 
LOS and Minimal Improvement 
Dependent 
Variables 
R  Square    F Adjusted R 
LOS 
Severity  
Interference 
   .024 
   .097 
   .015 
.578 
.230 
.376 
     -.017 
     -.032 
     -.026 
Note. Exploratory model predictors: Sociable and Confident Coping Styles. Severity and Interference 
scores are measured by the Brief Pain Inventory Short - Form. LOS = length of stay. 
p < .05. 
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Table 8 
Correlations Between Disabled Category and Outcome Variables 
Dependent Variables Pearson correlation Significance 
LOS          -.026       .428 
Severity           -.153       .141 
Interference          -.071       .311 
Note. Severity and Interference scores are measured by the Brief Pain Inventory Short - Form. LOS = 
length of stay. n = 51. Significance = 1-tailed.  
 
 
Analyses and Results for Hypotheses 3 and 4 
 For analysis of the third and fourth hypotheses, a dependent, paired-samples t-test 
using SPSS, version 19.0, was performed to determine the efficacy of inpatient treatment 
by comparing the difference between admission and discharge BPI-SF interference and 
severity scores. The mean admission BPI-SF interference score (M = 6.0188), 
significantly exceeded the discharge BPI-SF interference score (M = 2.7316), t(50) = 
8.545, p = .000. After inpatient treatment, the difference between BPI-SF interference 
admission and discharge scores was a little larger than one standard deviation (d = 
1.1963). The third hypothesis, stating that after inpatient treatment there was a significant 
difference between admission and discharge BPI-SF interference scores, was supported. 
Therefore, after inpatient treatment, interference of headaches during daily activities was 
significantly reduced. The mean admission BPI-SF severity score (M = 6.00), 
significantly exceeded the discharge BPI-SF severity score (M = 2.6373), t(50) = 10.765, 
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p = .000. After inpatient treatment, the difference between BPI-SF severity admission and 
discharge scores was a little larger than one standard deviation (d = 1.5112). The fourth 
hypothesis, stating after inpatient treatment there was a significant difference between 
admission and discharge BPI-SF severity scores, was supported. Therefore, after 
inpatient treatment there was a significant reduction in severity of headaches. 
Additionally, 59% of the sample obtained a score of 0 or 1 at discharge on the BPI-SF 
severity item asking on a scale of 1-10 for a rating of current pain.  
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Chapter Six: Discussion 
Summary of Findings 
 In review, the first and second alternate hypotheses were not supported. 
Specifically, the combination of psychological factors hypothesized (anxiety-tension, 
depression, a forceful coping style, pain sensitization, social isolation, future pessimism, 
and spiritual absence) did not predict a longer LOS or minimal improvement for this 
sample of inpatients with headache. The third and fourth alternate hypotheses were 
supported. Overall, inpatients in this sample experienced improvements in headache 
severity and interference of functioning from headaches after inpatient treatment. The 
confirmation of the third and fourth alternate hypotheses supports the contention that 
minimal improvement was a valid, accurate construct used in this study. Inpatient 
treatment efficacy was likely not a confounding variable conflicting with the ability of 
hypothesized psychological variables to predict minimal improvement. Inpatient 
treatment for this headache center may be an effective treatment option for patients with 
difficult-to-treat headache disorders.  
While reviewing data, a pattern was observed among refractory cases. 
Nonmarried participants with low Confident and Sociable scores and a high Denigrated 
score on the coping skills scales had minimal improvement after inpatient treatment in 
this sample. Therefore, exploratory analyses were conducted, which were not supported. 
Specifically, a nonmarried marital status in combination with a high Denigrated coping 
skills score was not significant in predicting minimal improvement or a longer LOS. 
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Likewise, low Confident and Sociable coping skills scores were not significant in 
predicting minimal improvement or a longer LOS. 
Significance of Findings 
Support for the efficacy of inpatient treatment for headache at this headache 
center was confirmed.  While confirmatory research is needed, patients with difficult-to-
treat headache conditions should be considered for inpatient treatment. Depending on 
future research on long-term outcomes of inpatient treatment, not only may inpatient 
treatment be effective for difficult-to-treat headache disorders, but it also may be a more 
cost-efficient option. 
As observed during the data review, a majority of the sample had elevations on 
the Pessimism and Pain Sensitization scales. Of the sample population, 94% had elevated 
Pain Sensitization scores and 84% had elevated Pessimism scores. For this sample, Pain 
Sensitization and Pessimism were likely not predictors of LOS and minimal 
improvement. The prevalence of the elevations likely precluded the predictive ability of 
those factors. Additionally, there were no significant correlations between Pessimism or 
Pain Sensitization scores and the outcome variables. Pessimism and Pain Sensitization 
may simply be factors characteristic of a difficult-to-treat headache disorder, rather than 
predictors of treatment outcome.  
The MBMD measure may be helpful in identifying patients who have or will have 
a difficult-to-treat headache disorder that requires inpatient treatment. As mentioned 
previously, Pain Sensitization and Pessimism scales may be indicators of a difficult-to-
treat headache disorder. A neurologist considering inpatient treatment for a patient could 
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refer during the decision-making process to the MBMD to check the Pain Sensitization 
and Pessimism scales. If the patient has elevations on these scales, he or she may have a 
difficult-to-treat headache disorder requiring more intensive inpatient treatment. 
There are several explanations for the unsupported first, second, and exploratory 
hypotheses. There may be factors that do not complicate the headache disorder that 
predict a longer LOS and minimal improvement. The logical conclusion that factors that 
complicate headache disorders predict minimal improvement or a longer LOS may not 
stand true. Commonplace factors, such as the schedule of the patient, the patient-doctor 
relationship, and the schedule of the doctor, should be explored in future studies for their 
ability to predict LOS and minimal improvement. Additionally, study limitations and the 
potential for medical factors to hold more weight in predicting LOS and minimal 
improvement are considerations for the unsupported hypotheses.  
Findings Related to Literature Review 
The sample demographics are important to consider in reference to the findings. 
As discussed in the literature review, headache disorders influenced by psychological 
comorbidity were more common for individuals in the 25 to 34 year age range (Bensenor 
et al., 2003). This sample, composed of 78% of adults ages 35 years and older, may have 
not had psychological comorbidity as a relevant factor in complicating the headache 
disorder. With adults from ages 55 to 64 years, functional deficits, such as physical 
limitations and lifestyle changes, influenced headache disorders (Bensenor et al., 2003). 
If the logic is true behind the theory driving the first two alternative hypotheses, the 
demographic characteristics of this sample may have precluded findings that could 
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support hypotheses composed of psychological constructs. Future research with older 
inpatient populations should explore functional deficits as predictors of treatment 
outcome. Likewise, considering that the prevalence of comorbid medical disorders is 
higher in an older adult population, future research should examine the types of medical 
disorders, the severity of medical disorders, and the number of medical disorders as 
predictors of minimal improvement and/or LOS.  
Relevance of Findings to the Theory and Practice of CBT 
 When considering CBT’s value to patients who suffer from headache, the 
function of psychological symptoms for patients with a headache disorder should be 
considered. Anxiety and depression are considered maladaptive coping strategies. 
However, anxiety and depression about the future is reasonable for someone with a 
debilitating headache disorder, who has experienced many failed treatment attempts. 
Perhaps anxiety and depression did not predict a negative outcome because, despite 
complicating the headache disorder, they serve the function for the patient of staying 
persistent with treatment efforts. For example, while thinking of better times can make 
someone depressed, it also may reflect hope that improvement is possible. While 
anticipating pain can make someone anxious, it also may reflect a desire to try to plan for 
a future without pain. Hassinger et al. (1999) proposed similar theories. They stated that 
pain may create a mobilization effect to use any coping strategy available, whether 
adaptive or not (Hassinger et al., 1999). Additionally, they proposed that maladaptive 
strategies may work for dealing with headaches but may not be effective when used in 
other situations (Hassinger et al., 1999). Certainly, there are adaptive ways to cope with 
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pain that exclude depression and anxiety. Encouraging optimistic thinking that reflects 
small, achievable, incremental steps of improvement is best for patients with headache. 
Findings Applicable to Future Research 
As opposed to depression and anxiety, which, while maladaptive, could serve a 
function of persistence with treatment, coping skills that function to maintain the 
headache condition rather than to ameliorate it may be critical in predicting a negative 
treatment outcome. A construct discussed in the literature review that may represent a 
coping skill that maintains the headache condition is what Gatchel described as the “sick 
role” (Dersh et al., 2002). Gatchel proposed that acute pain transforms into chronic pain 
when the patient begins to habituate to aspects of the sick role. Patients habituate to the 
sick role when they use the chronic condition as an excuse to avoid responsibility and 
social obligations. Interestingly, Lucas et al. (2007) reported that a lack of response to 
headache treatment was correlated with using acceptance as a coping strategy. In 
response to the finding, Lucas et al. (2007) proposed that acceptance may reflect 
helplessness, an unwillingness to take control of headaches, or a transition from seeking 
treatment to adaptation to the disorder. 
Suggestions for Future Research 
Researching the coping skills that patients with headache use throughout the 
progression of their headache disorder could be influential in determining the interaction 
among coping skills, medical characteristics of the headache disorder, and treatment 
outcome. Psychologists should collaborate with neurologists in order to identify stages in 
the progression of the headache disorder as determined by medical characteristics that 
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define the severity of the disorder. Neurologists also could define stages as they see fit 
that appropriately define the progression of the headache condition.  
Research also is needed to determine the coping skills that are specific to use by 
patients with headache. While many coping skills are identified as used by patients with 
pain and/or patients with functional impairments, these coping skills may or may not 
generalize to patients with headache. One area of interest is the assimilative and 
accommodative coping process as described by Rothermund and Brandtstädter (2003). 
They reported the process of coping with functional impairments in aging adults as a 
combination of assimilative and accommodative coping skills, used in conjunction with 
available resources. They proposed that when assimilative coping skills were no longer 
efficient to avoid losses of functional impairments, aging adults used accommodative 
coping skills to change their personal standards. Patients with headache may parallel this 
coping process. In the beginning of the headache disorder, patients may use assimilative 
coping skills, gathering all their resources and putting all their effort into avoiding losses 
associated with the headache condition. However, after many failed treatment efforts, 
patients with headache may change their personal standards to reflect acceptance of the 
headache disorder. While Rothermund and Brandtstädter (2003) proposed that 
accommodative coping strategies serve as a buffer, Lucas et al. (2007) proposed that 
acceptance may reflect a negative process involving helplessness. 
Tracking coping skills used by patients with during the progression of their 
headache disorder is preliminary in nature. Therefore, a case study design with only a few 
participants would be appropriate. The focus would be on determining the interaction 
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between the stages of the headache disorder and the function of the coping skills used. 
Finding valid, reliable measures of coping skills can help to determine predictors of 
negative treatment outcome. As mentioned previously, commonplace factors, such as the 
schedule of the patient, the patient-doctor relationship, and the schedule of the doctor, 
should be explored in future research.  
Research should be conducted to provide further support for the third and fourth 
hypotheses. To verify the efficacy of this headache center’s inpatient treatment program, 
a control and comparison group should be used. A wait-list control group, as well as an 
outpatient infusion treatment group, could be used in further research, comparing short-
term and long-term outcomes. Samples should be followed up every several months after 
discharge to determine the length of treatment outcome maintenance. Research 
comparing short-term and long-term outcomes of headache inpatient treatment with 
alternative treatment options is essential in determining whether inpatient treatment is a 
cost-efficient treatment option.  
Limitations 
While the alternative and exploratory hypotheses were not supported, null 
hypotheses were not confirmed. Despite the plausible explanations discussed to account 
for the absence of significant findings, the following limitations may have interfered with 
the model’s ability to predict minimal improvement and/or a longer LOS. Of most 
importance, the sample size was not large enough to detect significance. Another 
potential confounding variable is that the sample population consisted of individuals 
willing to participate. The characteristic of willingness to participate could be a factor 
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that precluded the sample from being representative of the inpatient population with 
headache, in addition to precluding experimental control of the study. Contrarily, Huber 
and Henrich (2003) reported an association between patients with migraine and social 
conformity, in which case a willingness to participate may be a characteristic that reflects 
a representative sample of the inpatient population. Additionally, the sample was 
homogenous, consisting primarily of Caucasian women. The homogenous sample, 
despite being similar to the general headache population, may be a confounding variable 
precluding experimental control of the study. The demographics of being a Caucasian 
woman may have been a characteristic interfering with the models’ ability to predict LOS 
and/or minimal improvement. In specific reference to the exploratory hypotheses, the 
cases observed to be refractory during data review may not have occurred frequently 
enough to warrant significance, or the sample size was not large enough to detect 
significance.  
Considering the limitations, another study with a larger, heterogeneous sample 
would be required to confirm or disconfirm the models’ ability to predict LOS and 
minimal improvement. Likewise, psychological factors may be lesser predictors, 
secondary to medical variables (i.e., response to medication) or environmental variables. 
Therefore, a larger than recommended sample size may be required to detect a 
psychological factor’s significance amongst potentially stronger variables. 
In reference to limitations related to the supported third and fourth alternative 
hypotheses, there was no control group used for comparison against the inpatient 
treatment. Therefore, the inpatient treatment may not have caused the significant 
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improvement in headache severity and interference of daily functioning from headaches. 
One cannot rule out that a sample under control-group conditions without treatment (in 
which inpatients are excused from responsibilities and under the care of nursing staff) 
would not demonstrate the same level of improvement as that of the treatment group. 
Likewise, considering that this headache center’s inpatient treatment program is adjusted 
to meet patients’ needs, there is variability in the treatment that each patient receives. The 
variability of each inpatient’s treatment protocol could represent confounding variables. 
This study obtained short-term outcomes; unfortunately, long-term outcomes of inpatient 
treatment efficacy were not a focus of this study.  
When replicating this study with an ample sample size, several considerations 
should be made. Additional key personnel should be trained; data on inpatient 
demographic characteristics should be collected prior to the start of data collection; 
measures used should be brief, simple, and completed on-site; and participants should be 
given time accommodations to complete measures. In order to accommodate for the 
conditions of inpatient treatment, an ample key personnel staff is required. For example, 
inpatients are often sleeping or unable to consent because of sedative effects of 
medication. Key personnel should be available to check-in throughout the day in order to 
obtain consenting participants. Likewise, key personnel are needed to collect outcome 
data in order to prevent loss of participants as a result of uncompleted discharge 
measures. Headache center staff have many responsibilities and should not be relied upon 
for study protocol.  
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Data regarding the inpatient sample demographics, particularly age, should be 
collected prior to the beginning of data collection in order to determine whether the 
hypotheses proposed are applicable to the characteristics of the sample population. 
However, despite collecting demographic data on inpatients with headache prior to data 
collection, determining the characteristics of inpatients willing to participate could still be 
difficult.  
The best practice is to use outcome measures that can be completed briefly in one 
time period, rather than measures that have to be completed on a daily basis, over the 
duration of the stay. Inpatients often did not complete the calendar in its entirety during 
the duration of the stay. Participants required time accommodations for completion of the 
MBMD. Inpatients were more willing to participate in the study if they had the option of 
completing the MBMD on a day when their condition permitted more functionality. 
Despite efforts to circulate the headache calendars to obtain the headache index score, at 
the conclusion of data collection, the obtaining of calendars did not seem to improve 
enough to permit their use as a reliable measure. If inpatients are required to bring from 
home a calendar or any other kind of measure to be used as a baseline measure, they will 
likely not bring the measure with them to the hospital. Baseline data are best collected at 
admission.  
Summary and Conclusions 
The stages of creating a model that includes medical, environmental, and 
psychological factors to predict negative treatment outcome for inpatients with headache 
are still preliminary. The complex nature of the interaction of factors to predict treatment 
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outcome is still largely unknown. Theories proposed regarding functional deficits and 
coping skills should be explored in an effort to discover a psychological factor amenable 
to treatment efforts that can, at least partly, predict a negative treatment outcome. 
Neurologists and psychologists should collaborate their research efforts in order to 
propose a model that includes medical, environmental, and psychological factors. 
Particularly, neurologists and psychologists should examine the interactions among 
medical, environmental, and psychological factors that may influence treatment outcome.  
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